<?xml version="1.0" encoding="UTF-8"?><!-- Normalized for easier text mining. --><xocs:doc xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.elsevier.com/xml/ja/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd http://schema.elsevier.com/dtds/document/fulltext/xcr/xocs-article.xsd"><xocs:meta><xocs:content-family>serial</xocs:content-family><xocs:content-type>JL</xocs:content-type><xocs:cid>286331</xocs:cid><xocs:srctitle>Stem Cell Reports</xocs:srctitle><xocs:normalized-srctitle>STEMCELLREPORTS</xocs:normalized-srctitle><xocs:orig-load-date>2013-10-31</xocs:orig-load-date><xocs:ew-transaction-id>2013-11-14T16:51:53</xocs:ew-transaction-id><xocs:eid>1-s2.0-S2213671113000921</xocs:eid><xocs:pii-formatted>S2213-6711(13)00092-1</xocs:pii-formatted><xocs:pii-unformatted>S2213671113000921</xocs:pii-unformatted><xocs:doi>10.1016/j.stemcr.2013.09.005</xocs:doi><xocs:item-stage>S300</xocs:item-stage><xocs:item-version-number>S300.1</xocs:item-version-number><xocs:item-weight>FULL-TEXT</xocs:item-weight><xocs:hub-eid>1-s2.0-S2213671113X00062</xocs:hub-eid><xocs:timestamp>2014-02-03T15:49:17.288084-05:00</xocs:timestamp><xocs:issns><xocs:issn-primary-formatted>2213-6711</xocs:issn-primary-formatted><xocs:issn-primary-unformatted>22136711</xocs:issn-primary-unformatted></xocs:issns><xocs:sponsored-access-type>UNLIMITED</xocs:sponsored-access-type><xocs:funding-body-id>NIH</xocs:funding-body-id><xocs:crossmark>true</xocs:crossmark><xocs:vol-first>1</xocs:vol-first><xocs:iss-first>5</xocs:iss-first><xocs:vol-iss-suppl-text>Volume 1, Issue 5</xocs:vol-iss-suppl-text><xocs:sort-order>9</xocs:sort-order><xocs:first-fp>464</xocs:first-fp><xocs:last-lp>478</xocs:last-lp><xocs:pages><xocs:first-page>464</xocs:first-page><xocs:last-page>478</xocs:last-page></xocs:pages><xocs:cover-date-orig><xocs:start-date>20131119</xocs:start-date></xocs:cover-date-orig><xocs:cover-date-text>19 November 2013</xocs:cover-date-text><xocs:cover-date-start>2013-11-19</xocs:cover-date-start><xocs:cover-date-year>2013</xocs:cover-date-year><xocs:hub-sec><xocs:hub-sec-title>Resource</xocs:hub-sec-title></xocs:hub-sec><xocs:document-type>article</xocs:document-type><xocs:document-subtype>fla</xocs:document-subtype><xocs:copyright-line>Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.</xocs:copyright-line><xocs:normalized-article-title>ANALYSISSOX2EXPRESSINGCELLPOPULATIONSDERIVEDHUMANPLURIPOTENTSTEMCELLS</xocs:normalized-article-title><xocs:normalized-first-auth-surname>BRAFMAN</xocs:normalized-first-auth-surname><xocs:normalized-first-auth-initial>D</xocs:normalized-first-auth-initial><xocs:item-toc><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Results</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Generation of a SOX2-GFP Reporter hESC Line by AAV Mediated Homologous Recombination</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>SOX2-GFP Marks Undifferentiated hESCs</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Dynamics of SOX2-GFP Expression during Neural Differentiation</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Isolation of SOX2-GFP<ce:sup loc="post">+</ce:sup> NPCs from Neural Rosettes</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>SOX2-GFP Marks the Anterior Foregut Endodermal Progeny of Differentiating hESCs</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Genome-wide Analysis of SOX2-GFP Reporter-Expressing Anterior Foregut Endoderm Cells</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Isolation of AFE Using Cell Surface Markers</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Discussion</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Gene Targeting Using AAV</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>SOX2, a Regulator of Pluripotency</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>SOX2, a Regulator of NPC Multipotency</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>SOX2, a Marker of Gut Tube Patterning</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Experimental Procedures</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Cells and Culture Conditions</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>AAV Production and Gene Targeting</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Neural Differentiation and NPC Culture</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Endodermal Differentiation</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>qRT-PCR</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>IF and FC</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>High-Throughput RNA-Seq</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:acknowledgment"><xocs:item-toc-section-title>Acknowledgments</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:appendices"><xocs:item-toc-section-title>Supplemental Information</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:bibliography"><xocs:item-toc-section-title>References</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc><xocs:references><xocs:ref-info refid="sref1"><xocs:ref-normalized-surname>ARNOLD</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>317</xocs:ref-first-fp><xocs:ref-last-lp>329</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref2"><xocs:ref-normalized-surname>ASURI</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>329</xocs:ref-first-fp><xocs:ref-last-lp>338</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref3"><xocs:ref-normalized-surname>AVILION</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>126</xocs:ref-first-fp><xocs:ref-last-lp>140</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref4"><xocs:ref-normalized-surname>BUECKER</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>535</xocs:ref-first-fp><xocs:ref-last-lp>546</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref5"><xocs:ref-normalized-surname>CHAMBERS</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>275</xocs:ref-first-fp><xocs:ref-last-lp>280</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref6"><xocs:ref-normalized-surname>CONG</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>819</xocs:ref-first-fp><xocs:ref-last-lp>823</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref7"><xocs:ref-normalized-surname>CRADICK</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref8"><xocs:ref-normalized-surname>DABDOUB</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>18396</xocs:ref-first-fp><xocs:ref-last-lp>18401</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref9"><xocs:ref-normalized-surname>DAVIS</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>42</xocs:ref-first-fp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref10"><xocs:ref-normalized-surname>DUBOIS</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>1011</xocs:ref-first-fp><xocs:ref-last-lp>1018</xocs:ref-last-lp><xocs:ref-normalized-initial>N</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref11"><xocs:ref-normalized-surname>ELKABETZ</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>152</xocs:ref-first-fp><xocs:ref-last-lp>165</xocs:ref-last-lp><xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref12"><xocs:ref-normalized-surname>ELLIS</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>148</xocs:ref-first-fp><xocs:ref-last-lp>165</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref13"><xocs:ref-normalized-surname>EVSEENKO</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>13742</xocs:ref-first-fp><xocs:ref-last-lp>13747</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref14"><xocs:ref-normalized-surname>FAGMAN</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>163</xocs:ref-first-fp><xocs:ref-last-lp>175</xocs:ref-last-lp><xocs:ref-normalized-initial>H</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref15"><xocs:ref-normalized-surname>FAUQUIER</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>2907</xocs:ref-first-fp><xocs:ref-last-lp>2912</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref16"><xocs:ref-normalized-surname>GRAHAM</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>749</xocs:ref-first-fp><xocs:ref-last-lp>765</xocs:ref-last-lp><xocs:ref-normalized-initial>V</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref17"><xocs:ref-normalized-surname>GREEN</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>267</xocs:ref-first-fp><xocs:ref-last-lp>272</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref18"><xocs:ref-normalized-surname>HANNA</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>9222</xocs:ref-first-fp><xocs:ref-last-lp>9227</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref19"><xocs:ref-normalized-surname>HIRATA</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>735</xocs:ref-first-fp><xocs:ref-last-lp>738</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref20"><xocs:ref-normalized-surname>HOCKEMEYER</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>731</xocs:ref-first-fp><xocs:ref-last-lp>734</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref21"><xocs:ref-normalized-surname>HOU</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>15644</xocs:ref-first-fp><xocs:ref-last-lp>15649</xocs:ref-last-lp><xocs:ref-normalized-initial>Z</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref22"><xocs:ref-normalized-surname>KELLY</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>750</xocs:ref-first-fp><xocs:ref-last-lp>756</xocs:ref-last-lp><xocs:ref-normalized-initial>O</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref23"><xocs:ref-normalized-surname>KHAN</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>1192</xocs:ref-first-fp><xocs:ref-last-lp>1199</xocs:ref-last-lp><xocs:ref-normalized-initial>I</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref24"><xocs:ref-normalized-surname>KHAN</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>482</xocs:ref-first-fp><xocs:ref-last-lp>501</xocs:ref-last-lp><xocs:ref-normalized-initial>I</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref25"><xocs:ref-normalized-surname>KIEFER</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>2356</xocs:ref-first-fp><xocs:ref-last-lp>2366</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref26"><xocs:ref-normalized-surname>KIERNAN</xocs:ref-normalized-surname><xocs:ref-pub-year>2005</xocs:ref-pub-year><xocs:ref-first-fp>1031</xocs:ref-first-fp><xocs:ref-last-lp>1035</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref27"><xocs:ref-normalized-surname>LEFEBVRE</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>2195</xocs:ref-first-fp><xocs:ref-last-lp>2214</xocs:ref-last-lp><xocs:ref-normalized-initial>V</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref28"><xocs:ref-normalized-surname>LI</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>8299</xocs:ref-first-fp><xocs:ref-last-lp>8304</xocs:ref-last-lp><xocs:ref-normalized-initial>W</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref29"><xocs:ref-normalized-surname>LONGMIRE</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>398</xocs:ref-first-fp><xocs:ref-last-lp>411</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref30"><xocs:ref-normalized-surname>LORTHONGPANICH</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>805</xocs:ref-first-fp><xocs:ref-last-lp>813</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref31"><xocs:ref-normalized-surname>MALI</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>823</xocs:ref-first-fp><xocs:ref-last-lp>826</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref32"><xocs:ref-normalized-surname>MANSOUR</xocs:ref-normalized-surname><xocs:ref-pub-year>1988</xocs:ref-pub-year><xocs:ref-first-fp>348</xocs:ref-first-fp><xocs:ref-last-lp>352</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref33"><xocs:ref-normalized-surname>MCKNIGHT</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>300</xocs:ref-first-fp><xocs:ref-last-lp>308</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref34"><xocs:ref-normalized-surname>MOU</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>385</xocs:ref-first-fp><xocs:ref-last-lp>397</xocs:ref-last-lp><xocs:ref-normalized-initial>H</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref35"><xocs:ref-normalized-surname>NICHOLS</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>487</xocs:ref-first-fp><xocs:ref-last-lp>492</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref36"><xocs:ref-normalized-surname>NICHOLS</xocs:ref-normalized-surname><xocs:ref-pub-year>1998</xocs:ref-pub-year><xocs:ref-first-fp>379</xocs:ref-first-fp><xocs:ref-last-lp>391</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref37"><xocs:ref-normalized-surname>OKUBO</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>2654</xocs:ref-first-fp><xocs:ref-last-lp>2659</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref38"><xocs:ref-normalized-surname>QUE</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>2521</xocs:ref-first-fp><xocs:ref-last-lp>2531</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref39"><xocs:ref-normalized-surname>QUE</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>1899</xocs:ref-first-fp><xocs:ref-last-lp>1907</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref40"><xocs:ref-normalized-surname>RADECKE</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>743</xocs:ref-first-fp><xocs:ref-last-lp>753</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref41"><xocs:ref-normalized-surname>RIZZINO</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>228</xocs:ref-first-fp><xocs:ref-last-lp>236</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref42"><xocs:ref-normalized-surname>ROSSANT</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>573</xocs:ref-first-fp><xocs:ref-last-lp>581</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref43"><xocs:ref-normalized-surname>SALIEM</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>2</xocs:ref-first-fp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref44"><xocs:ref-normalized-surname>SHIN</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>125</xocs:ref-first-fp><xocs:ref-last-lp>138</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref45"><xocs:ref-normalized-surname>SMITHARICA</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>51</xocs:ref-first-fp><xocs:ref-last-lp>62</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref46"><xocs:ref-normalized-surname>SONG</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>80</xocs:ref-first-fp><xocs:ref-last-lp>89</xocs:ref-last-lp><xocs:ref-normalized-initial>H</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref47"><xocs:ref-normalized-surname>STEWART</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>807</xocs:ref-first-fp><xocs:ref-last-lp>815</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref48"><xocs:ref-normalized-surname>TAKAHASHI</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>861</xocs:ref-first-fp><xocs:ref-last-lp>872</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref49"><xocs:ref-normalized-surname>TRAPNELL</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>562</xocs:ref-first-fp><xocs:ref-last-lp>578</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref50"><xocs:ref-normalized-surname>TRAPNELL</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>46</xocs:ref-first-fp><xocs:ref-last-lp>53</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref51"><xocs:ref-normalized-surname>WANG</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>364</xocs:ref-first-fp><xocs:ref-last-lp>368</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref52"><xocs:ref-normalized-surname>WANG</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>335</xocs:ref-first-fp><xocs:ref-last-lp>346</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref53"><xocs:ref-normalized-surname>WILLERT</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>448</xocs:ref-first-fp><xocs:ref-last-lp>452</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref54"><xocs:ref-normalized-surname>YUAN</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>e17540</xocs:ref-first-fp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref55"><xocs:ref-normalized-surname>ZOU</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>97</xocs:ref-first-fp><xocs:ref-last-lp>110</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info></xocs:references><xocs:attachment-metadata-doc><xocs:attachment-set-type>item</xocs:attachment-set-type><xocs:pii-formatted>S2213-6711(13)00092-1</xocs:pii-formatted><xocs:pii-unformatted>S2213671113000921</xocs:pii-unformatted><xocs:eid>1-s2.0-S2213671113000921</xocs:eid><xocs:doi>10.1016/j.stemcr.2013.09.005</xocs:doi><xocs:cid>286331</xocs:cid><xocs:timestamp>2013-11-19T10:00:31.815069-05:00</xocs:timestamp><xocs:path>/286331/1-s2.0-S2213671113X00062/1-s2.0-S2213671113000921/</xocs:path><xocs:cover-date-start>2013-11-19</xocs:cover-date-start><xocs:sponsored-access-type>UNLIMITED</xocs:sponsored-access-type><xocs:funding-body-id>NIH</xocs:funding-body-id><xocs:attachments><xocs:web-pdf><xocs:attachment-eid>1-s2.0-S2213671113000921-main.pdf</xocs:attachment-eid><xocs:filename>main.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:pdf-optimized>true</xocs:pdf-optimized><xocs:filesize>3095508</xocs:filesize><xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose><xocs:web-pdf-page-count>15</xocs:web-pdf-page-count><xocs:web-pdf-images><xocs:web-pdf-image><xocs:attachment-eid>1-s2.0-S2213671113000921-main_1.png</xocs:attachment-eid><xocs:filename>main_1.png</xocs:filename><xocs:extension>png</xocs:extension><xocs:filesize>130232</xocs:filesize><xocs:pixel-height>849</xocs:pixel-height><xocs:pixel-width>656</xocs:pixel-width><xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type><xocs:pdf-page-num>1</xocs:pdf-page-num></xocs:web-pdf-image></xocs:web-pdf-images></xocs:web-pdf><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-mmc3.xlsx</xocs:attachment-eid><xocs:file-basename>mmc3</xocs:file-basename><xocs:filename>mmc3.xlsx</xocs:filename><xocs:extension>xlsx</xocs:extension><xocs:filesize>65196</xocs:filesize><xocs:attachment-type>APPLICATION</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-mmc2.xlsx</xocs:attachment-eid><xocs:file-basename>mmc2</xocs:file-basename><xocs:filename>mmc2.xlsx</xocs:filename><xocs:extension>xlsx</xocs:extension><xocs:filesize>1735206</xocs:filesize><xocs:attachment-type>APPLICATION</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-gr3.jpg</xocs:attachment-eid><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>102902</xocs:filesize><xocs:pixel-height>691</xocs:pixel-height><xocs:pixel-width>506</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-gr4.jpg</xocs:attachment-eid><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>116787</xocs:filesize><xocs:pixel-height>677</xocs:pixel-height><xocs:pixel-width>506</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-gr7.jpg</xocs:attachment-eid><xocs:file-basename>gr7</xocs:file-basename><xocs:filename>gr7.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>142322</xocs:filesize><xocs:pixel-height>674</xocs:pixel-height><xocs:pixel-width>655</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-gr2.jpg</xocs:attachment-eid><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>166429</xocs:filesize><xocs:pixel-height>908</xocs:pixel-height><xocs:pixel-width>656</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-gr6.jpg</xocs:attachment-eid><xocs:file-basename>gr6</xocs:file-basename><xocs:filename>gr6.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>110304</xocs:filesize><xocs:pixel-height>660</xocs:pixel-height><xocs:pixel-width>505</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-gr1.jpg</xocs:attachment-eid><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>114265</xocs:filesize><xocs:pixel-height>742</xocs:pixel-height><xocs:pixel-width>505</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-gr5.jpg</xocs:attachment-eid><xocs:file-basename>gr5</xocs:file-basename><xocs:filename>gr5.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>88398</xocs:filesize><xocs:pixel-height>734</xocs:pixel-height><xocs:pixel-width>504</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-gr3.sml</xocs:attachment-eid><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>6458</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>120</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-gr4.sml</xocs:attachment-eid><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>7855</xocs:filesize><xocs:pixel-height>163</xocs:pixel-height><xocs:pixel-width>122</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-gr7.sml</xocs:attachment-eid><xocs:file-basename>gr7</xocs:file-basename><xocs:filename>gr7.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>9251</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>159</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-gr2.sml</xocs:attachment-eid><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>7800</xocs:filesize><xocs:pixel-height>163</xocs:pixel-height><xocs:pixel-width>118</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-gr6.sml</xocs:attachment-eid><xocs:file-basename>gr6</xocs:file-basename><xocs:filename>gr6.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>7285</xocs:filesize><xocs:pixel-height>163</xocs:pixel-height><xocs:pixel-width>125</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-gr1.sml</xocs:attachment-eid><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>6839</xocs:filesize><xocs:pixel-height>163</xocs:pixel-height><xocs:pixel-width>111</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-gr5.sml</xocs:attachment-eid><xocs:file-basename>gr5</xocs:file-basename><xocs:filename>gr5.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>5081</xocs:filesize><xocs:pixel-height>163</xocs:pixel-height><xocs:pixel-width>112</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000921-mmc1.pdf</xocs:attachment-eid><xocs:file-basename>mmc1</xocs:file-basename><xocs:filename>mmc1.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:filesize>2425691</xocs:filesize><xocs:attachment-type>APPLICATION</xocs:attachment-type></xocs:attachment></xocs:attachments></xocs:attachment-metadata-doc><xocs:refkeys><xocs:refkey3>BRAFMANX2013X464</xocs:refkey3><xocs:refkey4lp>BRAFMANX2013X464X478</xocs:refkey4lp><xocs:refkey4ai>BRAFMANX2013X464XD</xocs:refkey4ai><xocs:refkey5>BRAFMANX2013X464X478XD</xocs:refkey5></xocs:refkeys><xocs:open-access><xocs:oa-article-status is-open-access="1" is-open-archive="0">Full</xocs:oa-article-status><xocs:oa-access-effective-date>2013-09-25T14:48:01Z</xocs:oa-access-effective-date><xocs:oa-sponsor><xocs:oa-sponsor-type>ElsevierWaived</xocs:oa-sponsor-type></xocs:oa-sponsor><xocs:oa-user-license>http://creativecommons.org/licenses/by/3.0/</xocs:oa-user-license></xocs:open-access></xocs:meta><xocs:serial-item><article xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd" docsubtype="fla" version="5.2" xml:lang="en"><item-info><jid>STEMCR</jid><aid>37</aid><ce:pii>S2213-6711(13)00092-1</ce:pii><ce:doi>10.1016/j.stemcr.2013.09.005</ce:doi><ce:copyright type="other" year="2013">The Authors</ce:copyright></item-info><ce:floats><ce:figure id="fig1"><ce:label>Figure 1</ce:label><ce:caption id="cap0010"><ce:simple-para id="fspara0010" view="all">Generation and Characterization of SOX2-GFP Clones</ce:simple-para><ce:simple-para id="fspara0015" view="all">(A) Schematic of SOX2-GFP-targeting strategy. The top diagram represents the rAAV targeting vector used for targeting of the <ce:italic>SOX2</ce:italic> locus. The middle diagram depicts the genomic locus of SOX2, a single exon gene, and the bottom diagram illustrates the properly targeted <ce:italic>SOX2</ce:italic> locus. The genetic elements are not displayed to scale.</ce:simple-para><ce:simple-para id="fspara0020" view="all">(B) Southern blot using probe-1 (see diagram in [A])-confirmed targeting of the GFP gene to the endogenous <ce:italic>SOX2</ce:italic> locus in hSOX2-23 (23). The bands specific to the targeted allele are not observed in nontargeted wild-type cells (H9). Blots hybridized with probe 2 as well as uncropped blots can be found in <ce:cross-ref refid="app2" id="crosref0605">Figure S1</ce:cross-ref>.</ce:simple-para><ce:simple-para id="fspara0025" view="all">(C) Using fluorescence-based cell sorting, undifferentiated hSOX2-23 hESCs were separated on the basis of GFP expression. Wild-type (WT) nonfluorescing H9 hESCs were used as a control to set gates for cell sorting. NFC, nonfluorescent channel.</ce:simple-para><ce:simple-para id="fspara0030" view="all">(D) Gene expression analysis by quantitative RT-PCR (qRT-PCR) reveals that pluripotency markers <ce:italic>SOX2</ce:italic>, <ce:italic>OCT4</ce:italic>, and <ce:italic>NANOG</ce:italic> were enriched in the GFP<ce:sup loc="post">+</ce:sup> population. Data represent the mean ± SEM from three independent sorting experiments. Populations were compared using Student's t test. The asterisk denotes p &lt; 0.05.</ce:simple-para><ce:simple-para id="fspara0035" view="all">(E) Representative images of GFP, α-NANOG, and α-OCT4 IF of GFP<ce:sup loc="post">+</ce:sup> and GFP<ce:sup loc="post">-</ce:sup> cells (scale bar represents 200 μm).</ce:simple-para><ce:simple-para id="fspara0040" view="all">See also <ce:cross-ref refid="app2" id="crosref0610">Figures S1</ce:cross-ref> and <ce:cross-ref refid="app2" id="crosref0615">S2</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr1"/></ce:figure><ce:figure id="fig2"><ce:label>Figure 2</ce:label><ce:caption id="cap0015"><ce:simple-para id="fspara0045" view="all">Differentiation of SOX2-GFP hESC to Neurectoderm Lineages</ce:simple-para><ce:simple-para id="fspara0050" view="all">(A) Outline of protocol for differentiation of hESCs to NPCs. The soluble factors, substrate, and culture media at each stage are indicated. KO, knockout; KSR, KnockOut serum replacement.</ce:simple-para><ce:simple-para id="fspara0055" view="all">(B) Gene expression analysis for the neurectoderm marker <ce:italic>PAX6</ce:italic> during hESC differentiation to rosettes and NPCs (n = 3 independent experiments; error bars represent ± SEM; <ce:sup loc="pre">∗∗</ce:sup>p &lt; 0.01).</ce:simple-para><ce:simple-para id="fspara0060" view="all">(C) Flow cytometry analysis of TRA1-81 and GFP during NPC differentiation. Isotype controls used are listed in <ce:cross-ref refid="app2" id="crosref0620">Table S4</ce:cross-ref>.</ce:simple-para><ce:simple-para id="fspara0065" view="all">(D) IF analysis of GFP and SOX2 showed colocalization in NPCs (scale bar represents 100 μm).</ce:simple-para><ce:simple-para id="fspara0070" view="all">(E) Flow cytometry analysis of SOX1 expression in SOX2-GFP NPCs. SOX1 shows high coexpression with GFP. Isotype controls used are listed in <ce:cross-ref refid="app2" id="crosref0625">Table S4</ce:cross-ref>.</ce:simple-para><ce:simple-para id="fspara0075" view="all">(F) IF of SOX2-GFP hESCs differentiated to neural rosettes (scale bar represents 500 μm).</ce:simple-para><ce:simple-para id="fspara0080" view="all">(G) SOX2-GFP neural rosette cells were sorted on the basis of GFP expression. WT H9 rosettes were used as a control to set gates for cell sorting.</ce:simple-para><ce:simple-para id="fspara0085" view="all">(H) Gene expression analysis of sorted GFP<ce:sup loc="post">+</ce:sup> and GFP<ce:sup loc="post">-</ce:sup> cells showed high expression of NPC markers <ce:italic>SOX2</ce:italic>, <ce:italic>SOX1</ce:italic>, <ce:italic>NESTIN</ce:italic>, and <ce:italic>PAX6</ce:italic> in GFP<ce:sup loc="post">+</ce:sup> cells. Data represent the mean ± SEM from three independent sorting experiments. Populations were compared using Student's t test. The asterisk denotes p &lt; 0.05 and double asterisks denote p &lt; 0.01.</ce:simple-para><ce:simple-para id="fspara0090" view="all">(I) Flow cytometry analysis of SOX1 expression in FACS-purified GFP<ce:sup loc="post">+</ce:sup> cells. Replated GFP<ce:sup loc="post">+</ce:sup> cells maintained high expression of GFP and SOX1.</ce:simple-para></ce:caption><ce:link locator="gr2"/></ce:figure><ce:figure id="fig3"><ce:label>Figure 3</ce:label><ce:caption id="cap0020"><ce:simple-para id="fspara0095" view="all">Differentiation of hESCs to Anterior Foregut and Lung Endoderm</ce:simple-para><ce:simple-para id="fspara0100" view="all">(A) Outline of protocol for differentiation of hESCs to anterior foregut and lung progenitor cells. The soluble factors and culture media at each stage are shown.</ce:simple-para><ce:simple-para id="fspara0105" view="all">(B) Gene expression analysis of markers of undifferentiated hESCs (<ce:italic>NANOG</ce:italic>, <ce:italic>SOX2</ce:italic>), definitive endoderm (DE; <ce:italic>SOX17</ce:italic>), anterior foregut endoderm (AFE; <ce:italic>SOX2</ce:italic>, <ce:italic>FOXA2</ce:italic>, <ce:italic>TBX1</ce:italic>), and lung progenitor cell (LPC; <ce:italic>NKX2.1</ce:italic>, <ce:italic>SOX9</ce:italic>; n = 3 independent experiments; error bars represent ± S.E.M; <ce:sup loc="pre">∗</ce:sup>p &lt; 0.05; <ce:sup loc="pre">∗∗</ce:sup>p &lt; 0.01).</ce:simple-para><ce:simple-para id="fspara0110" view="all">(C) IF for NKX2.1 on day 13 LPC cultures (mean ± SD; scale bar represents 200 μm).</ce:simple-para><ce:simple-para id="fspara0115" view="all">See also <ce:cross-ref refid="app2" id="crosref0630">Figure S3</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr3"/></ce:figure><ce:figure id="fig4"><ce:label>Figure 4</ce:label><ce:caption id="cap0025"><ce:simple-para id="fspara0120" view="all">Characterization of SOX2-GFP Reporter hESCs Differentiation to AFE</ce:simple-para><ce:simple-para id="fspara0125" view="all">(A) Flow cytometry analysis of SOX2-GFP dynamics during hESC differentiation to AFE and LPC.</ce:simple-para><ce:simple-para id="fspara0130" view="all">(B) IF analysis of day 8 SOX2-GFP AFE cultures (scale bar represents 200 μm).</ce:simple-para><ce:simple-para id="fspara0135" view="all">(C) Gene expression analysis showed that AFE markers (<ce:italic>SOX2</ce:italic>, <ce:italic>TBX1</ce:italic>, <ce:italic>PAX9</ce:italic>, <ce:italic>HOXA1</ce:italic>, <ce:italic>HOXA2</ce:italic>) were highly enriched in GFP<ce:sup loc="post">+</ce:sup> cells. The expression levels of markers of the posterior foregut endoderm (PFE; <ce:italic>HNF1B</ce:italic>, <ce:italic>HNF4A</ce:italic>, <ce:italic>GATA6</ce:italic>, <ce:italic>CDX2</ce:italic>, <ce:italic>PDX1</ce:italic>) were higher in GFP<ce:sup loc="post">-</ce:sup> cells (n = 3 independent experiments; error bars represent ± SEM).</ce:simple-para><ce:simple-para id="fspara0140" view="all">(D) IF analysis of GFP<ce:sup loc="post">+</ce:sup>, GFP<ce:sup loc="post">-</ce:sup>, or unsorted control cells that were purified using fluorescence-based cell sorting at day 8 of differentiation, replated, and differentiated to LPCs. Expression of GFP and the LPC marker NKX2.1 was enriched in in-vitro-differentiated GFP<ce:sup loc="post">+</ce:sup> cells versus GFP<ce:sup loc="post">-</ce:sup> or unsorted control cells (mean ± SD; scale bar represents 200 μm).</ce:simple-para></ce:caption><ce:link locator="gr4"/></ce:figure><ce:figure id="fig5"><ce:label>Figure 5</ce:label><ce:caption id="cap0030"><ce:simple-para id="fspara0145" view="all">Genome-wide Expression Analysis of SOX2-GFP AFE</ce:simple-para><ce:simple-para id="fspara0150" view="all">(A) Day 8 AFE SOX2-GFP cells were separated by fluorescence-based cell sorting on the basis of GFP expression.</ce:simple-para><ce:simple-para id="fspara0155" view="all">(B) Scatter plot of log<ce:inf loc="post">10</ce:inf> RPKM in GFP<ce:sup loc="post">+</ce:sup> and GFP<ce:sup loc="post">-</ce:sup> day 8 AFE cells. Genes with a statistically significant difference are shown in red.</ce:simple-para><ce:simple-para id="fspara0160" view="all">(C) Selection of differentially expressed genes highlighting differences in gene expression patterns related to patterning and differentiation of the foregut endoderm.</ce:simple-para><ce:simple-para id="fspara0165" view="all">See also <ce:cross-ref refid="mmc2" id="crosref0635">Table S1</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr5"/></ce:figure><ce:figure id="fig6"><ce:label>Figure 6</ce:label><ce:caption id="cap0035"><ce:simple-para id="fspara0170" view="all">Cell Surface Markers Expressed in hESC-Derived AFE</ce:simple-para><ce:simple-para id="fspara0175" view="all">(A) HESC-differentiated AFE cells were sorted based on levels of CD56 and CD271 expression. Double-positive CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> and double-negative CD56<ce:sup loc="post">-</ce:sup>CD271<ce:sup loc="post">-</ce:sup> cells were replated and further differentiated in vitro to LPCs.</ce:simple-para><ce:simple-para id="fspara0180" view="all">(B) Flow cytometry analysis demonstrated that CD56 and CD271 expression correlates with GFP expression in day 8 AFE SOX2-GFP cells.</ce:simple-para><ce:simple-para id="fspara0185" view="all">(C) HESC-differentiated AFE cells were sorted on the basis of CD56 and CD271.</ce:simple-para><ce:simple-para id="fspara0190" view="all">(D) Flow cytometry analysis shows that GFP expression is highest in double-positive CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> compared to single-positive CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">-</ce:sup> or CD56<ce:sup loc="post">-</ce:sup>CD271<ce:sup loc="post">+</ce:sup> cells or double-negative CD56<ce:sup loc="post">-</ce:sup>CD271<ce:sup loc="post">-</ce:sup> cells.</ce:simple-para><ce:simple-para id="fspara0195" view="all">(E) Gene expression analysis reveals that the expression of the AFE markers <ce:italic>SOX2</ce:italic>, <ce:italic>TBX1</ce:italic>, and <ce:italic>PAX9</ce:italic> were highly enriched in the CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> cells. As expected, expression of CD56 and CD271 was enriched in CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> cells. Conversely, expression of the PFE markers <ce:italic>GATA6</ce:italic>, <ce:italic>HNF1B</ce:italic>, <ce:italic>HNF4A</ce:italic>, <ce:italic>CDX2</ce:italic>, and <ce:italic>PDX1</ce:italic> were enriched in CD56<ce:sup loc="post">-</ce:sup>CD271<ce:sup loc="post">-</ce:sup> cells.</ce:simple-para><ce:simple-para id="fspara0200" view="all">(F) Expression of LPC markers <ce:italic>NKX2.1</ce:italic> and <ce:italic>SOX9</ce:italic> was enriched in in-vitro-differentiated CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> cells. Data represent the mean ± SEM from three independent sorting experiments. Populations were compared using Student's t test. The number sign denotes p &gt; 0.05, asterisk denotes p &lt; 0.05, and double asterisks denote p &lt; 0.01.</ce:simple-para><ce:simple-para id="fspara0205" view="all">(G) IF analysis of CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> and CD56<ce:sup loc="post">-</ce:sup>CD271<ce:sup loc="post">-</ce:sup> cells that were purified by fluorescence-based cell sorting at day 8, replated, and differentiated to LPCs. Expression of the LPC marker NKX2.1 was enriched in in-vitro-differentiated CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> cells versus CD56<ce:sup loc="post">-</ce:sup>CD271<ce:sup loc="post">-</ce:sup> cells (scale bar represents 200 μm).</ce:simple-para><ce:simple-para id="fspara0210" view="all">See also <ce:cross-ref refid="app2" id="crosref0640">Figures S4</ce:cross-ref> and <ce:cross-ref refid="mmc3" id="crosref0645">Table S2</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr6"/></ce:figure><ce:figure id="fig7"><ce:label>Figure 7</ce:label><ce:caption id="cap0040"><ce:simple-para id="fspara0215" view="all">CD56 and CD271 Do Not Mark a SOX2<ce:sup loc="post">+</ce:sup> hESC or Neural Population</ce:simple-para><ce:simple-para id="fspara0220" view="all">Gene expression analysis of GFP<ce:sup loc="post">+</ce:sup> and GFP<ce:sup loc="post">-</ce:sup> undifferentiated hESCs (A) and neural rosette cells (B) shows that expression of <ce:italic>CD56</ce:italic> and <ce:italic>CD271</ce:italic> is not enriched in GFP<ce:sup loc="post">+</ce:sup> or GFP<ce:sup loc="post">-</ce:sup> cell populations (n = 3 independent experiments; error bars represent ± SEM, #p &gt; 0.05). Flow cytometry analysis demonstrates that CD56 and CD271 do not correlate with GFP expression in undifferentiated hESCs (C) and neural rosettes (D). Double-positive CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> AFE cells are not enriched for hESC- (E) or neural- (F) related markers (n = 3 independent experiments; error bars represent ± SEM; <ce:sup loc="pre">∗∗</ce:sup>p &lt; 0.01. DP, double-positive CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> AFE; DN, double-negative CD56<ce:sup loc="post">-</ce:sup>CD271<ce:sup loc="post">-</ce:sup> AFE; NS, no statistically significant difference).</ce:simple-para></ce:caption><ce:link locator="gr7"/></ce:figure></ce:floats><head><ce:article-footnote><ce:note-para id="ntpara0010" view="all">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</ce:note-para></ce:article-footnote><ce:dochead id="dhead0010"><ce:textfn>Resource</ce:textfn></ce:dochead><ce:title id="title0010">Analysis of SOX2-Expressing Cell Populations Derived from Human Pluripotent Stem Cells</ce:title><ce:author-group id="augrp0010"><ce:author id="au1"><ce:given-name>David A.</ce:given-name><ce:surname>Brafman</ce:surname><ce:cross-ref refid="aff1" id="crosref0010"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="cor1" id="crosref0015"><ce:sup loc="post">∗</ce:sup></ce:cross-ref><ce:e-address type="email" id="eadd0010">dbrafman@ucsd.edu</ce:e-address></ce:author><ce:author id="au2"><ce:given-name>Noel</ce:given-name><ce:surname>Moya</ce:surname><ce:cross-ref refid="aff1" id="crosref0020"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au3"><ce:given-name>Stephanie</ce:given-name><ce:surname>Allen-Soltero</ce:surname><ce:cross-ref refid="aff1" id="crosref0025"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au4"><ce:given-name>Thomas</ce:given-name><ce:surname>Fellner</ce:surname><ce:cross-ref refid="aff1" id="crosref0030"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="fn1" id="crosref0035"><ce:sup loc="post">3</ce:sup></ce:cross-ref></ce:author><ce:author id="au5"><ce:given-name>Megan</ce:given-name><ce:surname>Robinson</ce:surname><ce:cross-ref refid="aff1" id="crosref0040"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="fn2" id="crosref0045"><ce:sup loc="post">4</ce:sup></ce:cross-ref></ce:author><ce:author id="au6"><ce:given-name>Zoë L.</ce:given-name><ce:surname>McMillen</ce:surname><ce:cross-ref refid="aff1" id="crosref0050"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au7"><ce:given-name>Terry</ce:given-name><ce:surname>Gaasterland</ce:surname><ce:cross-ref refid="aff2" id="crosref0055"><ce:sup loc="post">2</ce:sup></ce:cross-ref></ce:author><ce:author id="au8"><ce:given-name>Karl</ce:given-name><ce:surname>Willert</ce:surname><ce:cross-ref refid="aff1" id="crosref0060"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="cor2" id="crosref0065"><ce:sup loc="post">∗∗</ce:sup></ce:cross-ref><ce:e-address type="email" id="eadd0015">kwillert@ucsd.edu</ce:e-address></ce:author><ce:affiliation id="aff1"><ce:label>1</ce:label><ce:textfn>Stem Cell Program, Department of Cellular and Molecular Medicine, UCSD, 9500 Gilman Drive, La Jolla, CA 92093-0695, USA</ce:textfn></ce:affiliation><ce:affiliation id="aff2"><ce:label>2</ce:label><ce:textfn>Scripps Genome Center, UCSD and Scripps Institution of Oceanography, 9500 Gilman Drive, La Jolla, CA 92093-0202, USA</ce:textfn></ce:affiliation><ce:correspondence id="cor1"><ce:label>∗</ce:label><ce:text>Corresponding author</ce:text></ce:correspondence><ce:correspondence id="cor2"><ce:label>∗∗</ce:label><ce:text>Corresponding author</ce:text></ce:correspondence><ce:footnote id="fn1"><ce:label>3</ce:label><ce:note-para id="ntpara0015" view="all">Present address: Lonza, Inc., 8830 Biggs Ford Road, Walkersville, MD 21793, USA</ce:note-para></ce:footnote><ce:footnote id="fn2"><ce:label>4</ce:label><ce:note-para id="ntpara0020" view="all">Present address: Fate Therapeutics, 3535 General Atomics Court, Suite 200, San Diego, CA 92121, USA</ce:note-para></ce:footnote></ce:author-group><ce:date-received day="22" month="5" year="2013"/><ce:date-revised day="24" month="9" year="2013"/><ce:date-accepted day="25" month="9" year="2013"/><ce:miscellaneous id="misc0010">Published: October 31, 2013</ce:miscellaneous><ce:abstract id="abs0010" view="all" class="author"><ce:section-title id="sectitle0010">Summary</ce:section-title><ce:abstract-sec id="abssec0010" view="all"><ce:simple-para id="abspara0010" view="all">SOX2 is involved in several cell and developmental processes, including maintenance of embryonic stem cells, differentiation of neural progenitor cells, and patterning of gut endoderm. To study its role in a human system, we generated a human embryonic stem cell (hESC) line harboring a reporter gene encoding GFP in the <ce:italic>SOX2</ce:italic> locus. This SOX2 reporter line faithfully recapitulates expression of the <ce:italic>SOX2</ce:italic> gene in undifferentiated human pluripotent stem cells (hPSCs), neural progenitor cells (NPCs), and anterior foregut endoderm (AFE). In undifferentiated hESCs, GFP expression corresponds to those cells with highest levels of expression of genes associated with the pluripotent state. In NPCs, expression of GFP can be employed to isolate cells expressing markers associated with NPC multipotency. In AFE, we used transcriptome-wide expression analysis to identify cell surface markers with elevated expression in this population, thereby facilitating isolation and purification of this hPSC-derived cell population.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class="author-highlights" id="abs0015" view="all"><ce:section-title id="sectitle0015">Highlights</ce:section-title><ce:abstract-sec id="abssec0015" view="all"><ce:simple-para id="abspara0015" view="all"><ce:list id="ulist0010"><ce:list-item id="u0010"><ce:para id="p0010" view="all">A SOX2-GFP hESC line is used to isolate and characterize multiple cell types</ce:para></ce:list-item><ce:list-item id="u0015"><ce:para id="p0015" view="all">A cell surface marker signature allows for the purification of endodermal progeny</ce:para></ce:list-item><ce:list-item id="u0020"><ce:para id="p0020" view="all">Targeted gene insertion with adeno-associated virus (AAV) is highly efficient</ce:para></ce:list-item></ce:list></ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class="teaser" id="abs0020" view="all"><ce:abstract-sec id="abssec0020" view="all"><ce:simple-para id="abspara0020" view="all"><ce:italic>SOX2</ce:italic> is expressed during multiple developmental stages. Brafman, Willert, and colleagues used human embryonic stem cells carrying a <ce:italic>SOX2</ce:italic> reporter to characterize its expression in undifferentiated cells and in neural and lung progenitor cells. This approach led to the identification of a cell surface signature to isolate prospective lung progenitors.</ce:simple-para></ce:abstract-sec></ce:abstract></head><body view="all"><ce:sections><ce:section id="sec1" view="all"><ce:section-title id="sectitle0020">Introduction</ce:section-title><ce:para id="p0025" view="all">Human pluripotent stem cells (hPSCs; including human embryonic stem cells [hESCs] and human induced pluripotent stem cells [hiPSCs]), provide a unique model system to study early human development and generate mature and functional cell types suitable for disease modeling, cell transplantation, and replacement therapies. Clinical applications of hPSCs will require a detailed understanding of the mechanisms that maintain their pluripotency or result in their differentiation to specific lineages. A particularly attractive method to study the underlying mechanisms that control pluripotency and differentiation is through the use of marker cell lines in which specific genes known to function in these processes are modified with a "molecular beacon," such as a gene encoding a fluorescent protein. Expression of such a tagged gene can be used to analyze and characterize the cells in which expression of this gene is either activated or repressed. Here, we describe the generation and characterization of such a marker line for the gene <ce:italic>SOX2</ce:italic>, which plays multiple roles in hPSC pluripotency and differentiation (<ce:cross-refs refid="bib1 bib27" id="crosrefs0010">Arnold et al., 2011; Lefebvre et al., 2007</ce:cross-refs>).</ce:para><ce:para id="p0030" view="all">SOX2 is a member of the SRY-related high-mobility-group box (SOX) transcription factors and controls cell fate and differentiation in a variety of cell types during development (<ce:cross-refs refid="bib25 bib27" id="crosrefs0015">Kiefer, 2007; Lefebvre et al., 2007</ce:cross-refs>). During the initial stages of development, SOX2 is expressed in the inner cell mass of the blastocyst (<ce:cross-refs refid="bib30 bib42" id="crosrefs0020">Lorthongpanich et al., 2008; Rossant, 2004</ce:cross-refs>) and along with OCT4 is responsible for regulating the pluripotent precursors that develop into the three germ layers (<ce:cross-ref refid="bib3" id="crosref0070">Avilion et al., 2003</ce:cross-ref>). SOX2 acts in coordination with other factors, such as NANOG (<ce:cross-ref refid="bib51" id="crosref0075">Wang et al., 2006</ce:cross-ref>) and OCT4 (<ce:cross-ref refid="bib36" id="crosref0080">Nichols et al., 1998</ce:cross-ref>), to maintain ESCs in a pluripotent state. Furthermore, ectopic expression of SOX2 along with OCT4, KLF4, and c-MYC can induce a pluripotent stem cell state from adult human fibroblasts, giving rise to hiPSCs (<ce:cross-ref refid="bib48" id="crosref0085">Takahashi et al., 2007</ce:cross-ref>).</ce:para><ce:para id="p0035" view="all">In addition to regulating the pluripotent state, SOX2 controls the formation of several cell types during fetal development, such as the nervous system (<ce:cross-ref refid="bib12" id="crosref0090">Ellis et al., 2004</ce:cross-ref>), anterior foregut endoderm (<ce:cross-ref refid="bib38" id="crosref0095">Que et al., 2007</ce:cross-ref>), and sensory cells of the taste bud and inner ear (<ce:cross-refs refid="bib8 bib26 bib37" id="crosrefs0025">Dabdoub et al., 2008; Kiernan et al., 2005; Okubo et al., 2006</ce:cross-refs>). SOX2 also regulates the progenitor cells in several adult tissues in the brain (<ce:cross-ref refid="bib12" id="crosref0100">Ellis et al., 2004</ce:cross-ref>), trachea (<ce:cross-ref refid="bib39" id="crosref0105">Que et al., 2009</ce:cross-ref>), and pituitary glands (<ce:cross-ref refid="bib15" id="crosref0110">Fauquier et al., 2008</ce:cross-ref>). A recent genetic lineage tracing study revealed that SOX2 regulates adult stem cells and tissue homeostasis in several adult epithelial tissues in the stomach, cervix, anus, testes, lens, and glands associated with the oral cavity, trachea, and cervix (<ce:cross-ref refid="bib1" id="crosref0115">Arnold et al., 2011</ce:cross-ref>).</ce:para><ce:para id="p0040" view="all">In this study, we describe the generation and characterization of a hESC line in which the endogenous <ce:italic>SOX2</ce:italic> locus was targeted to express GFP. The targeted reporter line facilitated the flow-cytometry-based purification and genetic assessment of SOX2-positive (SOX2<ce:sup loc="post">+</ce:sup>) cells in pluripotent hESCs as well as hESC-derived neural progenitor cells (NPCs) and anterior foregut endoderm (AFE). Genome-wide analysis of SOX2<ce:sup loc="post">+</ce:sup> AFE cells revealed a global gene expression signature that distinguished hESC-derived AFE cells from other cell types. This signature included two cell surface markers that permitted purification of SOX2<ce:sup loc="post">+</ce:sup> AFE cells from differentiating hESC cultures. Therefore, this SOX2-GFP reporter line is a valuable tool to dissect the role of SOX2 in regulating pluripotency, self-renewal, and differentiation.</ce:para></ce:section><ce:section id="sec2" view="all"><ce:section-title id="sectitle0025">Results</ce:section-title><ce:section id="sec2.1" view="all"><ce:section-title id="sectitle0030">Generation of a SOX2-GFP Reporter hESC Line by AAV Mediated Homologous Recombination</ce:section-title><ce:para id="p0045" view="all">Using a recombinant adeno-associated viral (rAAV)-based gene-targeting method, we inserted the gene-encoding GFP into the <ce:italic>SOX2</ce:italic> locus in H9 hESCs (<ce:cross-ref refid="fig1" id="crosref0120">Figure 1</ce:cross-ref><ce:float-anchor refid="fig1"/>A). Proper homologous recombination led to the replacement of the <ce:italic>SOX2</ce:italic> open reading frame with that of GFP and a neomycin selection cassette (SV40-Neo). After infection with rAAV and G418 drug selection, a total of 36 clones were expanded and screened by Southern blotting for homologous recombination events. Among these clones, 26 (72%) were found to carry the GFP-Neo cassette in the <ce:italic>SOX2</ce:italic> locus (<ce:cross-ref refid="app2" id="crosref0125">Figure S1</ce:cross-ref>A available online). No clones in which both <ce:italic>SOX2</ce:italic> alleles were disrupted were isolated. Our subsequent analysis focused on one of these clones, clone 23 (hSOX2-23). We confirmed appropriate gene targeting in this clone using multiple restriction digests followed by Southern blotting (<ce:cross-ref refid="fig1" id="crosref0130">Figures 1</ce:cross-ref>B, <ce:cross-ref refid="app2" id="crosref0135">S1</ce:cross-ref>B, and S1C). We did not observe nontargeted insertions of the rAAV sequences, and cells exhibited a normal karyotype (data not shown). Flow cytometry of hSOX2-23 revealed that the majority of the cells expressed GFP (<ce:cross-ref refid="fig1" id="crosref0140">Figure 1</ce:cross-ref>C). By comparison, a drug-selected clone, hSOX2-25, which was negative for targeted insertion (<ce:cross-ref refid="app2" id="crosref0145">Figure S1</ce:cross-ref>A), showed no detectable GFP (<ce:cross-ref refid="app2" id="crosref0150">Figure S2</ce:cross-ref>A). Despite only having one copy of <ce:italic>SOX2</ce:italic>, hSOX2-23 had similar levels of <ce:italic>SOX2, OCT4</ce:italic>, and <ce:italic>NANOG</ce:italic> expression as hSOX2-25 and wild-type (WT) hESCs (<ce:cross-ref refid="app2" id="crosref0155">Figure S2</ce:cross-ref>B). Moreover, the percentage of GFP-positive (GFP<ce:sup loc="post">+</ce:sup>) cells in hSOX2-23 was constant over more than 20 passages. Immunofluorescence (IF) staining of hSOX2-23 showed that 100% of GFP<ce:sup loc="post">+</ce:sup> cells expressed SOX2 protein (<ce:cross-ref refid="app2" id="crosref0160">Figure S2</ce:cross-ref>C). Additionally, hSOX2-23 colonies had characteristic hESC morphology (<ce:cross-ref refid="app2" id="crosref0165">Figure S2</ce:cross-ref>D) and expressed markers of the undifferentiated state, such as NANOG (<ce:cross-ref refid="app2" id="crosref0170">Figure S2</ce:cross-ref>E). These results show that this rAAV-based gene-targeting method can be used to efficiently disrupt genes by homologous recombination. In addition, the <ce:italic>SOX2</ce:italic>-GFP hESC marker line can be used to monitor SOX2 expression in undifferentiated hESCs.</ce:para></ce:section><ce:section id="sec2.2" view="all"><ce:section-title id="sectitle0035">SOX2-GFP Marks Undifferentiated hESCs</ce:section-title><ce:para id="p0050" view="all">To investigate whether GFP expression in hSOX2-23 could be used to monitor the differentiation status of hESCs, we performed flow cytometry analysis of hSOX2-23 grown in culture conditions that maintain hESCs in an undifferentiated state. In these conditions, &gt;90% of the cells were GFP<ce:sup loc="post">+</ce:sup> (<ce:cross-ref refid="fig1" id="crosref0175">Figure 1</ce:cross-ref>C). Quantitative RT-PCR (qRT-PCR) revealed that expression of <ce:italic>SOX2</ce:italic>, <ce:italic>OCT4</ce:italic>, and <ce:italic>NANOG</ce:italic> was significantly higher in GFP<ce:sup loc="post">+</ce:sup> compared to GFP negative (GFP<ce:sup loc="post">-</ce:sup>) cells (<ce:cross-ref refid="fig1" id="crosref0180">Figure 1</ce:cross-ref>D), indicating that GFP expression marked undifferentiated cells. To determine if GFP expression could be used to remove differentiating cells from pluripotent hESC cultures, we cultured purified GFP<ce:sup loc="post">+</ce:sup> and GFP<ce:sup loc="post">-</ce:sup> cells in conditions that support undifferentiated growth for hESCs. The GFP<ce:sup loc="post">+</ce:sup> cells grew as compact colonies characteristic of the undifferentiated state, whereas the GFP<ce:sup loc="post">-</ce:sup> cells had a fibroblast-like morphology typical of differentiating hESCs (<ce:cross-ref refid="app2" id="crosref0185">Figure S2</ce:cross-ref>F). Moreover, cultured GFP<ce:sup loc="post">+</ce:sup> cells maintained high GFP expression, whereas cultured GFP<ce:sup loc="post">-</ce:sup> cells failed to express detectable levels of GFP (<ce:cross-ref refid="fig1" id="crosref0190">Figure 1</ce:cross-ref>E). Finally, IF staining revealed that cultured GFP<ce:sup loc="post">+</ce:sup> cells maintained high NANOG and OCT4 expression, whereas cultured GFP<ce:sup loc="post">-</ce:sup> cells showed little NANOG or OCT4 expression (<ce:cross-ref refid="fig1" id="crosref0195">Figure 1</ce:cross-ref>E). These results suggest that the SOX2-GFP marker can be used to monitor the undifferentiated state of hESCs.</ce:para></ce:section><ce:section id="sec2.3" view="all"><ce:section-title id="sectitle0040">Dynamics of SOX2-GFP Expression during Neural Differentiation</ce:section-title><ce:para id="p0055" view="all">In addition to being a master regulator of hPSCs, SOX2 is a marker of multipotent NPCs and is necessary for their maintenance in the nervous system (<ce:cross-ref refid="bib12" id="crosref0200">Ellis et al., 2004</ce:cross-ref>). To assess regulation of the SOX2-GFP marker during neurectoderm differentiation, we developed a serum-free differentiation protocol based on previously published methods (<ce:cross-ref refid="fig2" id="crosref0205">Figure 2</ce:cross-ref><ce:float-anchor refid="fig2"/>A; <ce:cross-refs refid="bib5 bib28" id="crosrefs0030">Chambers et al., 2009; Li et al., 2011</ce:cross-refs>). In brief, NPCs were manually picked from embryoid body-derived rosettes, dissociated, replated, and maintained as proliferative cells in the presence of fibroblast growth factor 2 (FGF2) and epidermal growth factor (EGF) (<ce:cross-ref refid="bib44" id="crosref0210">Shin et al., 2006</ce:cross-ref>). Expression of SOX2 and the neural-specific marker <ce:italic>PAX6</ce:italic> peaked upon NPC formation (<ce:cross-ref refid="fig2" id="crosref0215">Figure 2</ce:cross-ref>B). Flow cytometry confirmed the progressive loss of the pluripotency marker TRA-1-81 as hESCs differentiated to rosettes and NPCs (<ce:cross-ref refid="fig2" id="crosref0220">Figure 2</ce:cross-ref>C). Concurrently, GFP expression declined upon differentiation to the rosette stage and then re-emerged in NPCs (<ce:cross-ref refid="fig2" id="crosref0225">Figure 2</ce:cross-ref>C). This pattern of GFP expression is consistent with previous studies (<ce:cross-ref refid="bib5" id="crosref0230">Chambers et al., 2009</ce:cross-ref>). IF of hSOX2-23 NPCs revealed that 100% of GFP<ce:sup loc="post">+</ce:sup> NPCs were SOX2<ce:sup loc="post">+</ce:sup> (<ce:cross-ref refid="fig2" id="crosref0235">Figure 2</ce:cross-ref>D). Additionally, a high percentage of GFP<ce:sup loc="post">+</ce:sup> NPCs coexpressed the NPC marker SOX1 as monitored by flow cytometry (<ce:cross-ref refid="fig2" id="crosref0240">Figure 2</ce:cross-ref>E). Together, these results demonstrate that SOX2-GFP expression can be used to monitor neural differentiation of hESCs.</ce:para></ce:section><ce:section id="sec2.4" view="all"><ce:section-title id="sectitle0045">Isolation of SOX2-GFP<ce:sup loc="post">+</ce:sup> NPCs from Neural Rosettes</ce:section-title><ce:para id="p0060" view="all">Fluorescence analysis of rosette stage cultures revealed that GFP expression was isolated to the neuroepithelial-like rosette structures that are manually dissected to obtain NPCs (<ce:cross-ref refid="bib11" id="crosref0245">Elkabetz et al., 2008</ce:cross-ref>; <ce:cross-ref refid="fig2" id="crosref0250">Figure 2</ce:cross-ref>F). To investigate if GFP expression could allow for the isolation of NPCs without manual dissection, we dissociated rosette-stage cultures into single cells and isolated GFP<ce:sup loc="post">+</ce:sup> cells using fluorescence-based cell sorting (<ce:cross-ref refid="fig2" id="crosref0255">Figure 2</ce:cross-ref>G). Gene expression analysis of GFP<ce:sup loc="post">+</ce:sup> and GFP<ce:sup loc="post">-</ce:sup> cell populations by qRT-PCR revealed that the GFP<ce:sup loc="post">+</ce:sup> rosette stage cells expressed higher amounts of the NPC markers <ce:italic>SOX1</ce:italic>, <ce:italic>SOX2</ce:italic>, <ce:italic>PAX6</ce:italic>, and <ce:italic>NESTIN</ce:italic> than the GFP<ce:sup loc="post">-</ce:sup> rosette stage cells (<ce:cross-ref refid="fig2" id="crosref0260">Figure 2</ce:cross-ref>H). Subsequent culture of GFP<ce:sup loc="post">+</ce:sup> rosette stage cells revealed that these cells maintained high expression of GFP and the NPC marker SOX1 (<ce:cross-ref refid="fig2" id="crosref0265">Figure 2</ce:cross-ref>I). Thus, SOX2-GFP expression can be used to isolate NPCs from rosette stage cultures.</ce:para></ce:section><ce:section id="sec2.5" view="all"><ce:section-title id="sectitle0050">SOX2-GFP Marks the Anterior Foregut Endodermal Progeny of Differentiating hESCs</ce:section-title><ce:para id="p0065" view="all"><ce:italic>SOX2</ce:italic> is expressed in the developing AFE, with the highest levels in the future esophagus, trachea, and lung (<ce:cross-ref refid="bib38" id="crosref0270">Que et al., 2007</ce:cross-ref>). To investigate if the hSOX2-23 line could be used to isolate cells with an AFE identity from differentiating hESCs, we used a modified version of previously published protocols (<ce:cross-ref refid="fig3" id="crosref0275">Figure 3</ce:cross-ref><ce:float-anchor refid="fig3"/>A; <ce:cross-refs refid="bib17 bib29 bib34" id="crosrefs0035">Green et al., 2011; Longmire et al., 2012; Mou et al., 2012</ce:cross-refs>). To generate definitive endoderm (DE), the precursor cell population for AFE, hSOX2-23s were treated with Activin A and Wnt3a (stage 1). Subsequent differentiation to AFE was achieved through addition of bone morphogenetic protein (BMP) antagonists noggin and SB431542 (stage 2). Maturation to a lung progenitor cell (LPC) phenotype was achieved through addition of BMP4, FGF2, and Wnt3a. At stage 1, expression of the DE marker <ce:italic>SOX17</ce:italic> peaked while expression of the pluripotency marker <ce:italic>NANOG</ce:italic> declined (<ce:cross-ref refid="fig3" id="crosref0280">Figure 3</ce:cross-ref>B). Similarly, at stage 2, we observed high expression levels of AFE markers <ce:italic>FOXA2</ce:italic> and <ce:italic>TBX1</ce:italic> (<ce:cross-ref refid="fig3" id="crosref0285">Figure 3</ce:cross-ref>B). In contrast, expression of the posterior foregut endoderm (PFE) markers <ce:italic>HNF6</ce:italic> and <ce:italic>PDX1</ce:italic> was not detectable (<ce:cross-ref refid="app2" id="crosref0290">Figure S3</ce:cross-ref>A). <ce:italic>SOX2</ce:italic>, as well as <ce:italic>TBX1</ce:italic>, expression re-emerged during differentiation to AFE (<ce:cross-ref refid="fig3" id="crosref0295">Figure 3</ce:cross-ref>B), but not to PFE (<ce:cross-ref refid="app2" id="crosref0300">Figure S3</ce:cross-ref>B), suggesting the SOX2-GFP reporter line can be employed to isolate cells with properties associated with AFE. Furthermore, LPC markers <ce:italic>NKX2.1</ce:italic> and <ce:italic>SOX9</ce:italic> showed high levels of expression at stage 3 (<ce:cross-ref refid="fig3" id="crosref0305">Figure 3</ce:cross-ref>B). Consistent with previous publications, this protocol yielded approximately 25% NKX2.1-positive (NKX2.1<ce:sup loc="post">+</ce:sup>) LPCs (<ce:cross-ref refid="fig3" id="crosref0310">Figure 3</ce:cross-ref>C).</ce:para><ce:para id="p0070" view="all">Next, we tested whether GFP expression in hSOX2-23 hESCs could be used to monitor anterior foregut differentiation and to purify AFE progeny. After an initial decrease in GFP expression as cells exited the pluripotent state and differentiated toward DE, a GFP<ce:sup loc="post">+</ce:sup> cell population re-emerged and expanded during the AFE stage (<ce:cross-ref refid="fig4" id="crosref0315">Figure 4</ce:cross-ref><ce:float-anchor refid="fig4"/>A). Upon subsequent differentiation to LPC, GFP expression disappeared. This temporal pattern of GFP expression was consistent with our analysis of <ce:italic>SOX2</ce:italic> gene expression. Differentiation of hSOX2-23 into AFE yielded densely packed GFP<ce:sup loc="post">+</ce:sup> cells, often surrounding an empty lumen-like cavity (<ce:cross-ref refid="fig4" id="crosref0320">Figure 4</ce:cross-ref>B). qRT-PCR analysis revealed that expression of the AFE markers <ce:italic>SOX2</ce:italic>, <ce:italic>TBX1</ce:italic>, <ce:italic>PAX9</ce:italic>, <ce:italic>HOXA1</ce:italic>, and <ce:italic>HOXA2</ce:italic> was highly enriched in the GFP<ce:sup loc="post">+</ce:sup> population, whereas the PFE markers <ce:italic>HNF1B</ce:italic>, <ce:italic>HNF4A</ce:italic>, <ce:italic>GATA6</ce:italic>, <ce:italic>CDX2</ce:italic>, and <ce:italic>PDX1</ce:italic> were enriched in the GFP<ce:sup loc="post">-</ce:sup> population (<ce:cross-ref refid="fig4" id="crosref0325">Figure 4</ce:cross-ref>C). To test the potential of these cells to develop into LPCs, sorted GFP<ce:sup loc="post">+</ce:sup> and GFP<ce:sup loc="post">-</ce:sup> AFE cells and unsorted control AFE cells were replated and differentiated to LPCs using previously described methods (<ce:cross-refs refid="bib17 bib29 bib34" id="crosrefs0040">Green et al., 2011; Longmire et al., 2012; Mou et al., 2012</ce:cross-refs>). IF analysis for NKX2.1, the earliest marker of LPCs distinguishing it from the remainder of the AFE (<ce:cross-refs refid="bib14 bib39" id="crosrefs0045">Fagman et al., 2011; Que et al., 2009</ce:cross-refs>), revealed that &gt;90% of GFP<ce:sup loc="post">+</ce:sup> cells differentiated into NKX2.1<ce:sup loc="post">+</ce:sup> lung endoderm (<ce:cross-ref refid="fig4" id="crosref0330">Figure 4</ce:cross-ref>D). In contrast, the unsorted AFE population or the GFP<ce:sup loc="post">-</ce:sup> populations generated significantly fewer SOX2<ce:sup loc="post">+</ce:sup> and NKX2.1<ce:sup loc="post">+</ce:sup> cells (<ce:cross-ref refid="fig4" id="crosref0335">Figure 4</ce:cross-ref>D). Together, these results demonstrate that GFP<ce:sup loc="post">+</ce:sup> cells exhibit properties of AFE and are capable of differentiating in vitro into derivatives of AFE, including NKX2.1<ce:sup loc="post">+</ce:sup> LPCs.</ce:para></ce:section><ce:section id="sec2.6" view="all"><ce:section-title id="sectitle0055">Genome-wide Analysis of SOX2-GFP Reporter-Expressing Anterior Foregut Endoderm Cells</ce:section-title><ce:para id="p0075" view="all">To define a global gene expression signature of AFE, we performed whole transcriptome sequencing (RNA sequencing [RNA-seq]) of sorted GFP<ce:sup loc="post">+</ce:sup> and GFP<ce:sup loc="post">-</ce:sup> cells from differentiated AFE cultures (Figure <ce:cross-ref refid="fig1" id="crosref0340">5</ce:cross-ref>A<ce:float-anchor refid="fig5"/> and <ce:cross-ref refid="mmc2" id="crosref5010a">Table S1</ce:cross-ref>). We identified 1,943 genes with differential expression between these two cell populations, with the expression of 1,038 genes elevated in the GFP<ce:sup loc="post">+</ce:sup> population and 905 genes elevated in the GFP<ce:sup loc="post">-</ce:sup> population (<ce:cross-ref refid="fig5" id="crosref0350">Figure 5</ce:cross-ref>B). This signature included genes involved in signaling pathways (Wnt, FGF, Notch, BMP, and RA signaling) known to play a role in the patterning of the foregut endoderm. Moreover, this genetic signature included genes known to define developing AFE and PFE (<ce:cross-ref refid="fig5" id="crosref0355">Figure 5</ce:cross-ref>C). Specifically, expression of AFE markers <ce:italic>SOX2</ce:italic>, <ce:italic>HOXA1</ce:italic>, <ce:italic>HOXA2</ce:italic>, and <ce:italic>IRX5</ce:italic> was highly enriched in the GFP<ce:sup loc="post">+</ce:sup> population (<ce:cross-ref refid="fig5" id="crosref0360">Figure 5</ce:cross-ref>C). Conversely, expression of PFE markers <ce:italic>HNF1A</ce:italic>, <ce:italic>HNF1B</ce:italic>, <ce:italic>HNF6</ce:italic>, and <ce:italic>GATA6</ce:italic> as well as the DE markers <ce:italic>SOX17</ce:italic> and <ce:italic>FOXA1</ce:italic> were increased in the GFP<ce:sup loc="post">-</ce:sup> cells (<ce:cross-ref refid="fig5" id="crosref0365">Figure 5</ce:cross-ref>C). Early markers of tissues derived from AFE, such as the lung (<ce:italic>IRX1</ce:italic> and <ce:italic>SOX9</ce:italic>), thyroid (<ce:italic>PAX8</ce:italic>), pharynx (<ce:italic>FGF8</ce:italic>), esophagus (<ce:italic>DLX3</ce:italic> and <ce:italic>OTX1</ce:italic>), and stomach (<ce:italic>EYA4</ce:italic>), showed higher levels of expression in GFP<ce:sup loc="post">+</ce:sup> cells (<ce:cross-ref refid="fig5" id="crosref0370">Figure 5</ce:cross-ref>C). In contrast, expression of genes associated with tissues derived from PFE, such as intestine (<ce:italic>CDX2</ce:italic>), liver (<ce:italic>AFP</ce:italic>), and pancreas (<ce:italic>PDX1</ce:italic> and <ce:italic>NGN3</ce:italic>), were lower in GFP<ce:sup loc="post">+</ce:sup> cells (<ce:cross-ref refid="fig5" id="crosref0375">Figure 5</ce:cross-ref>C). Collectively, this RNA-seq analysis suggests that GFP<ce:sup loc="post">+</ce:sup> cells isolated from differentiating cultures are enriched for cells with an AFE gene expression profile.</ce:para></ce:section><ce:section id="sec2.7" view="all"><ce:section-title id="sectitle0060">Isolation of AFE Using Cell Surface Markers</ce:section-title><ce:para id="p0080" view="all">To develop a cell surface marker "signature" for SOX2<ce:sup loc="post">+</ce:sup> AFE cells, we mined our RNA-seq data for genes encoding transmembrane proteins with differential expression levels between GFP<ce:sup loc="post">+</ce:sup> and GFP<ce:sup loc="post">-</ce:sup> cells (<ce:cross-ref refid="mmc3" id="crosref5020a">Table S2</ce:cross-ref>). qRT-PCR confirmed that several genes encoding cell surface markers were differentially expressed in the GFP<ce:sup loc="post">+</ce:sup> and GFP<ce:sup loc="post">-</ce:sup> populations (<ce:cross-ref refid="app2" id="crosref0380">Figures S4</ce:cross-ref>A and <ce:cross-ref refid="fig4" id="crosref0385">4</ce:cross-ref>B). Flow cytometry with antibodies directed against these cell surface markers revealed that staining of CD56 (neural cell adhesion molecule [NCAM]) and CD271 (nerve growth factor receptor [NGFR]) correlated with GFP expression in day 8 AFE cells (<ce:cross-ref refid="fig6" id="crosref0390">Figures 6</ce:cross-ref>A and 6B<ce:float-anchor refid="fig6"/>, and <ce:cross-ref refid="app2" id="crosref0395">S4</ce:cross-ref>C). Consistent with the RNA-seq data, qRT-PCR analysis confirmed that transcripts for both CD56 and CD271 were enriched in the GFP<ce:sup loc="post">+</ce:sup> populations (<ce:cross-ref refid="app2" id="crosref0400">Figure S4</ce:cross-ref>B). Similarly, gene expression analysis of cells at various stages of differentiation revealed that CD56 and CD271 expression peaked at AFE (<ce:cross-ref refid="app2" id="crosref0405">Figure S4</ce:cross-ref>D).</ce:para><ce:para id="p0085" view="all">Using fluorescence-based cell sorting of day 8 AFE cultures with antibodies to CD56 and CD271 (<ce:cross-ref refid="fig6" id="crosref0410">Figures 6</ce:cross-ref>A and 6C), we demonstrated that double-positive CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> cells expressed higher levels of GFP than single-positive CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">-</ce:sup> or CD56<ce:sup loc="post">-</ce:sup>CD271<ce:sup loc="post">+</ce:sup> cells or double-negative CD56<ce:sup loc="post">-</ce:sup>CD271<ce:sup loc="post">-</ce:sup> cells (<ce:cross-ref refid="fig6" id="crosref0415">Figure 6</ce:cross-ref>D). When AFE cells differentiated from WT H9 hESCs were sorted for these cell surface markers, expression of AFE markers <ce:italic>SOX2</ce:italic>, <ce:italic>TBX1</ce:italic>, and <ce:italic>PAX9</ce:italic> was increased in double-positive cells compared with double-negative cells (<ce:cross-ref refid="fig6" id="crosref0420">Figure 6</ce:cross-ref>E). Conversely, expression of PFE markers <ce:italic>GATA6</ce:italic>, <ce:italic>HNF1B</ce:italic>, <ce:italic>HNF4A</ce:italic>, <ce:italic>CDX2</ce:italic>, and <ce:italic>PDX1</ce:italic> was higher in double-negative cells compared with double-positive cells (<ce:cross-ref refid="fig6" id="crosref0425">Figure 6</ce:cross-ref>E). To investigate if double-positive CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> cells were capable of differentiating into more mature lung progeny, as assessed by <ce:italic>NKX2.1</ce:italic> expression, we replated CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> and CD56<ce:sup loc="post">-</ce:sup>CD271<ce:sup loc="post">-</ce:sup> cells after cell sorting and differentiated them to LPCs. Gene expression analysis revealed that expression of the LPC markers <ce:italic>NKX2.1</ce:italic> and <ce:italic>SOX9</ce:italic> was enriched in the CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> population relative to the CD56<ce:sup loc="post">-</ce:sup>CD271<ce:sup loc="post">-</ce:sup> (<ce:cross-ref refid="fig6" id="crosref0430">Figure 6</ce:cross-ref>F). Additionally, IF analysis for NKX2.1 revealed that a higher percentage of the CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> cells differentiated into NKX2.1<ce:sup loc="post">+</ce:sup> lung endoderm compared to the CD56<ce:sup loc="post">-</ce:sup>CD271<ce:sup loc="post">-</ce:sup> cells (<ce:cross-ref refid="fig6" id="crosref0435">Figure 6</ce:cross-ref>G). Interestingly, cells with highest NKX2.1 expression were clustered with bright staining along the edges, an organization reminiscent of an epithelial cell population as may be expected for lung epithelial precursors. These data demonstrate that cell enrichment strategies for CD56 and CD271 significantly increase the percentage of cells with AFE gene expression patterns from differentiated hESC cultures.</ce:para><ce:para id="p0090" view="all">Although our analysis suggested that CD56 and CD271 marked SOX2<ce:sup loc="post">+</ce:sup> AFE cells, it was unclear if these cell surface markers specified SOX2<ce:sup loc="post">+</ce:sup> cells in undifferentiated hESC or neurectoderm cultures. Gene expression analysis revealed that neither <ce:italic>CD56</ce:italic> nor <ce:italic>CD271</ce:italic> expression was enriched in GFP<ce:sup loc="post">+</ce:sup> hESCs (<ce:cross-ref refid="fig7" id="crosref0440">Figure 7</ce:cross-ref><ce:float-anchor refid="fig7"/>A) or neural rosette cells (<ce:cross-ref refid="fig7" id="crosref0445">Figure 7</ce:cross-ref>B). Flow cytometry revealed that neither CD56 nor CD271 correlated with GFP expression in hESCs (<ce:cross-ref refid="fig7" id="crosref0450">Figure 7</ce:cross-ref>C) or neural rosette cells (<ce:cross-ref refid="fig7" id="crosref0455">Figure 7</ce:cross-ref>D). Because SOX2 is also expressed in undifferentiated hESCs and neurectoderm cells, we wanted to confirm that we were not enriching these rare cell types in our CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> AFE cultures. To that end, there was little expression of the pluripotency markers <ce:italic>OCT4</ce:italic> and <ce:italic>NANOG</ce:italic> in CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> AFE cells when compared to undifferentiated hESCs (<ce:cross-ref refid="fig7" id="crosref0460">Figure 7</ce:cross-ref>E). Additionally, there was no difference in expression of these genes between the CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> and CD56<ce:sup loc="post">-</ce:sup>CD271<ce:sup loc="post">-</ce:sup> AFE cells. Furthermore, expression of the neurectoderm markers <ce:italic>SOX1</ce:italic>, <ce:italic>PAX6</ce:italic>, and <ce:italic>NES</ce:italic> was significantly lower in CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> AFE cells compared to neural rosette cells (<ce:cross-ref refid="fig7" id="crosref0465">Figure 7</ce:cross-ref>F). Finally, there was no difference in expression of these genes among the CD56<ce:sup loc="post">+</ce:sup>CD271<ce:sup loc="post">+</ce:sup> and CD56<ce:sup loc="post">-</ce:sup>CD271<ce:sup loc="post">-</ce:sup> AFE cells. Collectively, these studies suggest that CD56 and CD271 expression correlates only with the SOX2<ce:sup loc="post">+</ce:sup> AFE cell population.</ce:para></ce:section></ce:section><ce:section id="sec3" view="all"><ce:section-title id="sectitle0065">Discussion</ce:section-title><ce:para id="p0095" view="all">In this work, we employed a human SOX2-GFP reporter cell line to characterize distinct cell populations in which <ce:italic>SOX2</ce:italic> is known to be expressed, including undifferentiated hPSCs, NPCs, and anterior foregut endodermal cells (AFEs). We showed that this reporter line can be used to monitor the differentiation status of cells, isolate and purify distinct cell populations, and identify genes with expression patterns associated with these distinct cell populations. This approach is particularly valuable for the design and development of protocols for the directed differentiation of hPSCs into cell populations suitable for transplantation studies, disease modeling, and drug screening.</ce:para><ce:section id="sec3.1" view="all"><ce:section-title id="sectitle0070">Gene Targeting Using AAV</ce:section-title><ce:para id="p0100" view="all">Gene targeting in hPSCs has met many challenges, and to date, methods for homologous recombination (HR) in hPSCs are not as commonplace as in mouse embryonic stem cells (mESCs). The reasons for differences in gene targeting between mESCs and hPSCs remain poorly understood. It has been suggested that mESCs represent an early "naive" developmental stage akin to the inner cell mass of the blastocyst, whereas hPSCs represent a later "primed" developmental state that resembles the epiblast (<ce:cross-ref refid="bib35" id="crosref0470">Nichols and Smith, 2009</ce:cross-ref>), and that this difference accounts for the differences observed in transgenesis and HR (<ce:cross-ref refid="bib4" id="crosref0475">Buecker et al., 2010</ce:cross-ref>). In fact, Buecker et al. showed that, in hPSCs that had been genetically manipulated to obtain a naive mESC-like state, HR targeting efficiencies approached those typically observed in mESCs (<ce:cross-ref refid="bib4" id="crosref0480">Buecker et al., 2010</ce:cross-ref>). However, conversion of hPSCs to a naive state with biological characteristics similar to mESCs remains technically challenging (<ce:cross-ref refid="bib18" id="crosref0485">Hanna et al., 2010</ce:cross-ref>).</ce:para><ce:para id="p0105" view="all">Based on several previous publications (<ce:cross-refs refid="bib23 bib24" id="crosrefs0050">Khan et al., 2010, 2011</ce:cross-refs>), we explored the utility of adeno-associated virus (AAV) as a method to improve gene targeting efficiencies in hPSCs. For <ce:italic>SOX2</ce:italic>, a gene that is highly expressed in undifferentiated hPSCs, gene targeting rates were greater than 70%. Similar targeting efficiencies in hPSCs using AAV have been reported by others (<ce:cross-refs refid="bib2 bib23 bib24 bib45" id="crosrefs0055">Asuri et al., 2012; Khan et al., 2010, 2011; Smith-Arica et al., 2003</ce:cross-refs>), indicating that AAV offers a highly efficient and robust approach to target genes for HR in hPSCs.</ce:para><ce:para id="p0110" view="all">Currently, conventional methods for gene targeting utilize standard transduction methods, such as electroporation, to introduce linearized DNA constructs with homology arms of 3-5 kb flanking positive (e.g., neomycin or hygromycin) and negative (ganciclovir) selection cassettes (<ce:cross-ref refid="bib32" id="crosref0490">Mansour et al., 1988</ce:cross-ref>). These approaches are extremely inefficient, with targeting efficiencies varying between &lt;0.1% and 5%. An alternative method to improve gene modification efficiencies involves the introduction of site-specific, double-stranded breaks into the genome using zinc finger nucleases (<ce:cross-refs refid="bib9 bib55" id="crosrefs0060">Davis and Stokoe, 2010; Zou et al., 2009</ce:cross-refs>), transcription activator-like effector nucleases (<ce:cross-ref refid="bib20" id="crosref0495">Hockemeyer et al., 2011</ce:cross-ref>), or the RNA-guided CRISPR-Cas system (<ce:cross-refs refid="bib6 bib21 bib31" id="crosrefs0065">Cong et al., 2013; Hou et al., 2013; Mali et al., 2013</ce:cross-refs>). Whereas these approaches are promising, site-directed specificity has been difficult to control and off-target cleavage events are common (<ce:cross-refs refid="bib7 bib40" id="crosrefs0070">Cradick et al., 2013; Radecke et al., 2010</ce:cross-refs>). In addition, bacterial artificial chromosomes (BACs) have been successfully used for site-specific targeting in hPSCs at efficiencies of up to 25% (<ce:cross-ref refid="bib46" id="crosref0500">Song et al., 2010</ce:cross-ref>); however, the use of BACs is technically challenging due to complex cloning methods.</ce:para><ce:para id="p0115" view="all">In contrast to these methods, AAV offers features that make it an attractive alternative means for gene targeting. First, the AAV genome is relatively compact (∼4.8 kb) and genetic engineering is accordingly straightforward. Aside from two flanking palindromic inverted terminal repeats, the entire genome can be engineered to contain the desired genetic elements, including drug selection cassettes, reporter genes, and homology arms to promote HR. Second, AAV is a single-stranded DNA virus and, upon infection and entry into the cell, this single-stranded piece of DNA provides an ideal substrate for the endogenous DNA repair machinery, thereby significantly increasing gene-targeting efficiencies. Third, AAV rarely integrates itself nonspecifically into the genome and it consequently has become an attractive system to create viral vectors for gene therapy.</ce:para></ce:section><ce:section id="sec3.2" view="all"><ce:section-title id="sectitle0075">SOX2, a Regulator of Pluripotency</ce:section-title><ce:para id="p0120" view="all">Along with <ce:italic>OCT4</ce:italic> and <ce:italic>NANOG</ce:italic>, <ce:italic>SOX2</ce:italic> is one of the master regulators of the pluripotent state in hPSCs (<ce:cross-ref refid="bib41" id="crosref0505">Rizzino, 2009</ce:cross-ref>). However, analysis of <ce:italic>SOX2</ce:italic> expression in hPSCs relies on the fixation of cells, which limits their use in subsequent molecular and biological studies. We were able to use our SOX2-GFP reporter line to detect and enrich for SOX2 expression in live hPSC cultures. Consistent with previous reports that describe hPSCs as heterogeneous cultures with varying levels of expression of pluripotency-associated genes (<ce:cross-ref refid="bib47" id="crosref0510">Stewart et al., 2006</ce:cross-ref>), we observed varying levels of SOX2-GFP expression in our hPSC cultures. Purification and analysis of these cells revealed higher expression levels of pluripotency-associated genes in SOX2<ce:sup loc="post">+</ce:sup> versus SOX2<ce:sup loc="post">-</ce:sup> cells. Moreover, subsequent culture of purified SOX2<ce:sup loc="post">+</ce:sup> and SOX2<ce:sup loc="post">-</ce:sup> cells revealed that they maintained distinct developmental states.</ce:para></ce:section><ce:section id="sec3.3" view="all"><ce:section-title id="sectitle0080">SOX2, a Regulator of NPC Multipotency</ce:section-title><ce:para id="p0125" view="all">NPCs derived from hPSCs offer a unique model system to study neural development and are a possible source of cells to treat a variety of neurodegenerative disorders. In the adult brain, SOX2 functions to maintain the multipotent state of endogenous NPCs (<ce:cross-ref refid="bib16" id="crosref0515">Graham et al., 2003</ce:cross-ref>). Further, SOX2 is a marker of multipotent NPCs derived from hPSCs (<ce:cross-refs refid="bib5 bib28" id="crosrefs0075">Chambers et al., 2009; Li et al., 2011</ce:cross-refs>). Consistent with these studies, we were able to use SOX2-GFP reporter expression to isolate a homogeneous population of SOX2<ce:sup loc="post">+</ce:sup> NPCs from heterogeneously differentiating cultures. Moreover, we demonstrated that these cells were enriched for neural markers and maintained high expression of NPC markers over subsequent passages. These SOX2<ce:sup loc="post">+</ce:sup> NPCs will be useful for future applications, such as neural transplantation, genetic profiling, or epigenetic analysis.</ce:para></ce:section><ce:section id="sec3.4" view="all"><ce:section-title id="sectitle0085">SOX2, a Marker of Gut Tube Patterning</ce:section-title><ce:para id="p0130" view="all">Cells derived from AFE, including those comprising the lung, trachea, and thyroid, are of significant interest for many regenerative medicine and disease-modeling purposes. SOX2 has been implicated in regulating the patterning of the foregut endoderm along the anterior-posterior axis and specifying AFE (<ce:cross-ref refid="bib38" id="crosref0520">Que et al., 2007</ce:cross-ref>). Using our SOX2-GFP reporter line, we were able to monitor foregut endoderm differentiation and use flow cytometry to isolate a pure SOX2<ce:sup loc="post">+</ce:sup> AFE population from differentiating cultures and perform subsequent genetic and developmental studies. Using RNA-seq, we were able to identify a global gene expression signature that defines SOX2<ce:sup loc="post">+</ce:sup> AFE cells in heterogeneously differentiating hPSC cultures. Because AFE exists only transiently during in vivo development, our SOX2 reporter line allows for the in vitro study of a developmental stage that is difficult to analyze in vivo. Finally, we demonstrated that subsequent in vitro differentiation of sorted SOX2<ce:sup loc="post">+</ce:sup> cells led to the generation of cells that uniformly express NKX2.1, a transcriptional regulator of lung and thyroid development. Together, this cellular platform will be useful for future studies examining the developmental and genetic programs that contribute to foregut, lung, and thyroid development.</ce:para><ce:para id="p0135" view="all">Flow-cytometry-based purification of intermediate progenitor cell populations of differentiating hPSCs followed by subsequent differentiation is an alternative approach for generating highly enriched and well-defined mature cell populations required for cell-based therapies and disease modeling (<ce:cross-ref refid="bib33" id="crosref0525">McKnight et al., 2010</ce:cross-ref>). Recently, transgenic cell marking combined with genome-wide expression profiling and flow cytometry have been used to develop flow-cytometry-based strategies for the purification of DE, immature cardiomyocytes, and pancreatic endoderm (<ce:cross-refs refid="bib10 bib22 bib52" id="crosrefs0080">Dubois et al., 2011; Kelly et al., 2011; Wang et al., 2011</ce:cross-refs>). However, flow-cytometry-based strategies have not yet been developed for the purification of AFE. Using our genome-wide expression analysis of reporter-expressing AFE cells, we identified two cell surface markers, CD56 (also known as NCAM) and CD271 (also known as NGFR), that permitted the isolation of SOX2<ce:sup loc="post">+</ce:sup> AFE cells. Although their names imply neural expression (and hence ectodermal origin), CD56/NCAM and CD271/NGFR are not completely restricted to the derivatives of the ectodermal germ layer. For example, these cell surface markers also define cells of the mesodermal (<ce:cross-ref refid="bib13" id="crosref0530">Evseenko et al., 2010</ce:cross-ref>), mesenchymal (<ce:cross-ref refid="bib43" id="crosref0535">Saliem et al., 2012</ce:cross-ref>), and other nonneural lineages (<ce:cross-ref refid="bib54" id="crosref0540">Yuan et al., 2011</ce:cross-ref>). In the future, this cell surface panel will allow for the prospective isolation and study of pure AFE cells from potentially any hPSC line.</ce:para><ce:para id="p0140" view="all">In conclusion, we have developed a cell-based tool that will allow for the study of SOX2<ce:sup loc="post">+</ce:sup> cells, not only in pluripotent hPSCs, but also in various endodermal and neural-related cell types. Furthermore, this reporter cell line will enable high-throughput screening approaches to identify secreted factors or small molecules that promote endodermal or neural differentiation of hPSCs. Finally, because SOX2 is one of the few regulatory genes expressed in both pluripotent and differentiated cells, future genetic and epigenetic analysis of the SOX2<ce:sup loc="post">+</ce:sup> cell populations will allow for the identification of common mechanisms that control hPSC pluripotency and differentiation.</ce:para></ce:section></ce:section><ce:section id="sec4" role="materials-methods" view="all"><ce:section-title id="sectitle0090">Experimental Procedures</ce:section-title><ce:section id="sec4.1" view="all"><ce:section-title id="sectitle0095">Cells and Culture Conditions</ce:section-title><ce:para id="p0145" view="all">Media compositions and sources for all cell lines are listed in the <ce:cross-ref refid="app2" id="crosref0545">Supplemental Information</ce:cross-ref> section. All hESC cultures were supplemented with 30 ng/ml FGF2. Mouse embryonic fibroblast-conditioned medium (MEF-CM) was produced by culturing MEFs in hESC medium for 24 hr followed by sterile filtering. Cells were routinely passaged with Accutase, washed, and replated at a density 4.25 × 10<ce:sup loc="post">4</ce:sup>/cm<ce:sup loc="post">2</ce:sup>. All work with hESCs was reviewed and approved by the University of California at San Diego (UCSD) Stem Cell Research Oversight Committee, project numbers 100210ZX and 090807ZX.</ce:para></ce:section><ce:section id="sec4.2" view="all"><ce:section-title id="sectitle0100">AAV Production and Gene Targeting</ce:section-title><ce:para id="p0150" view="all">The design and construction of the <ce:italic>SOX2</ce:italic>-targeting vector is described in the <ce:cross-ref refid="app2" id="crosref0550">Supplemental Experimental Procedures</ce:cross-ref>. Supernatants carrying infectious AAV particles were produced as previously described (<ce:cross-ref refid="bib19" id="crosref0555">Hirata et al., 2002</ce:cross-ref>) with a detailed protocol available here: <ce:inter-ref xlink:href="http://vectorcore.salk.edu/protocols/AAV%20Production%20Protocol.doc" id="intref0010" xlink:type="simple">http://vectorcore.salk.edu/protocols/AAV Production Protocol.doc</ce:inter-ref>. H9 cells on Matrigel in MEF-CM were infected with the SOX2-GFP AAV-2 supernatants at approximately 10<ce:sup loc="post">10</ce:sup> genome copies. After 24 hr, virus was removed and G418 (50 μg/ml) was applied for 2 weeks. After 2 weeks, colonies were manually picked and transferred to fresh MEF feeder cells in 96-well plates. Genomic DNA extracted from G418<ce:sup loc="post">R</ce:sup> clones was analyzed using Southern blot analysis with probes to the left (probe 1) and right (probe 2) homology arms.</ce:para></ce:section><ce:section id="sec4.3" view="all"><ce:section-title id="sectitle0105">Neural Differentiation and NPC Culture</ce:section-title><ce:para id="p0155" view="all">Methods to derive and passage NPCs are described in detail in the <ce:cross-ref refid="app2" id="crosref0560">Supplemental Experimental Procedures</ce:cross-ref>. Briefly, embryoid bodies formed over 5 days in the presence of 50 ng/ml recombinant mouse noggin (R&amp;D Systems) and 0.5 μM Dorsomorphin (Tocris Bioscience) were cultured in neural induction media. After 7 days, neural rosettes were isolated, dissociated into single cells, and plated onto poly-L-ornithine (10 μg/ml) and mouse laminin (5 μg/ml)-coated dishes in neural induction media with 10 ng/ml mouse FGF2 and 10 ng/ml mouse EGF2.</ce:para></ce:section><ce:section id="sec4.4" view="all"><ce:section-title id="sectitle0110">Endodermal Differentiation</ce:section-title><ce:para id="p0160" view="all">Methods to differentiate hESCs to endodermal derivatives are described in detail in the <ce:cross-ref refid="app2" id="crosref0565">Supplemental Experimental Procedures</ce:cross-ref>. Briefly, to generate DE, hESCs were cultured for 3 days in 100 ng/ml recombinant human Activin A with the first day supplemented with 30 ng/ml Wnt3a (<ce:cross-ref refid="bib53" id="crosref0570">Willert et al., 2003</ce:cross-ref>). For differentiation of AFE, DE cells were treated for 5 days with 200 ng/ml noggin and 10 μM SB-431542. For differentiation to LPCs, AFE cells were treated for 5 days with 100 ng/ml Wnt3a, 10 ng/ml mouse keratinocyte growth factor (KGF/FGF7), 100 ng/ml mouse FGF2, 10 ng/ml mouse BMP4, 10 ng/ml mouse FGF10, and 10 ng/ml EGF. For differentiation to PFE, DE cells were cultured in 50 ng/ml KGF for 3 days and then in 50 ng/ml noggin, 0.25 μM 3-keto-N-(aminoethyl-aminocaproyl-dihydrocinnamoyl)cyclopamine, and 2 μM retinoic acid for 3 days.</ce:para></ce:section><ce:section id="sec4.5" view="all"><ce:section-title id="sectitle0115">qRT-PCR</ce:section-title><ce:para id="p0165" view="all">RNA was isolated using TRIzol and reverse transcription was performed by means of qScript cDNA Supermix. qRT-PCR was carried out using TaqMan probes (<ce:cross-ref refid="app2" id="crosref0575">Table S3</ce:cross-ref>) and TaqMan Fast Universal PCR Master Mix on a 7900HT Real Time PCR machine. Gene expression was normalized to 18S rRNA levels. All experiments were performed with three technical replicates.</ce:para></ce:section><ce:section id="sec4.6" view="all"><ce:section-title id="sectitle0120">IF and FC</ce:section-title><ce:para id="p0170" view="all">Detailed protocols for IF and flow cytometry (FC) are provided in the <ce:cross-ref refid="app2" id="crosref0580">Supplemental Information</ce:cross-ref> section. For IF, cultures were in 4% (w/v) paraformaldehyde, permeabilized with 0.2% (v/v) Triton X-100, washed, and incubated overnight in primary antibody. Secondary antibodies were incubated 1 hr. All antibodies and dilutions are listed in <ce:cross-ref refid="app2" id="crosref0585">Table S4</ce:cross-ref>. Nucleic acids were stained for DNA with Hoechst 33342 (2 μg/ml). Cells were imaged on an Olympus Fluoview 1000. Image quantation was performed by counting a minimum of nine fields at 20× magnification. For FC, cells were dissociated into single cells with Accutase, washed with fluorescence-activated cell sorting (FACS) buffer, resuspended at 5 × 10<ce:sup loc="post">6</ce:sup> cells per 100 μl, stained with indicated antibodies (<ce:cross-ref refid="app2" id="crosref0590">Table S4</ce:cross-ref>), and analyzed and sorted with a FACSCanto or FACSAria2 (BD Biosciences). FC data were analyzed with FACSDiva software. For replating experiments, cells were stained with appropriate antibodies, sorted in FACS buffer, and replated with 10 nM Y27632. Isotype negative controls are listed in <ce:cross-ref refid="app2" id="crosref0595">Table S4</ce:cross-ref>. For sorting experiments in which cells were separated on the basis of GFP expression, wild-type nonfluorescing cells were used as a negative control.</ce:para></ce:section><ce:section id="sec4.7" view="all"><ce:section-title id="sectitle0125">High-Throughput RNA-Seq</ce:section-title><ce:para id="p0175" view="all">RNA-seq of RNA from SOX2-GFP<ce:sup loc="post">+</ce:sup> and SOX2-GFP<ce:sup loc="post">-</ce:sup> AFE cells was performed as described in the <ce:cross-ref refid="app2" id="crosref0600">Supplemental Information</ce:cross-ref> section, and differential gene expression analysis was performed with TopHat and Cufflinks (<ce:cross-refs refid="bib49 bib50" id="crosrefs0085">Trapnell et al., 2012, 2013</ce:cross-refs>). Reads per kilobase of exon per million mapped reads (RPKM) were calculated for each gene and used as an estimate of expression levels.</ce:para></ce:section></ce:section></ce:sections><ce:acknowledgment id="ack0010" view="all"><ce:section-title id="sectitle0130">Acknowledgments</ce:section-title><ce:para id="p0180" view="all">We would like to thank Eric O'Connor of the UCSD/Sanford Consortium for Regenerative Medicine (SCRM) Human Embryonic Stem Cell Core for assistance with cell sorting and the SCRM Viral Vector Core for production of rAAV. D.A.B. was supported by funding from the UCSD Stem Cell Program and a gift from Michael and Nancy Kaehr. This research was supported in part by the National Institute of Diabetes and Digestive and Kidney Diseases Beta Cell Biology Consortium (5U01DK089567-02) and the California Institute for Regenerative Medicine (RT2-02064). This work was made possible in part by the CIRM Major Facilities grant (FA1-00607) to the Sanford Consortium for Regenerative Medicine.</ce:para></ce:acknowledgment><ce:appendices view="all"><ce:section id="app1" view="compact-standard"><ce:section-title id="sectitle0135">Supplemental Information</ce:section-title><ce:para id="p0185" view="all">Supplemental Information includes Supplemental Experimental Procedures, four figures, and four tables and can be found with this article online at <ce:inter-ref xlink:href="doi:10.1016/j.stemcr.2013.09.005" id="intref0015" xlink:type="simple">http://dx.doi.org/10.1016/j.stemcr.2013.09.005</ce:inter-ref>.</ce:para></ce:section><ce:section id="app2" view="extended"><ce:section-title id="sectitle0140">Supplemental Information</ce:section-title><ce:para id="p0190" view="all"><ce:display><ce:e-component id="mmc1"><ce:label>Document S1. Supplemental Experimental Procedures, Figures S1-S4, and Tables S3 and S4</ce:label><ce:link locator="mmc1"/></ce:e-component></ce:display><ce:display><ce:e-component id="mmc2"><ce:label>Table S1. RNA-Seq Data of GFP<ce:sup loc="post">+</ce:sup> and GFP- Day 8 AFE Cells, Related to Figure 5</ce:label><ce:link locator="mmc2"/></ce:e-component></ce:display><ce:display><ce:e-component id="mmc3"><ce:label>Table S2. RNA-Seq Data of Cell Surface Markers Differentially Expressed in GFP<ce:sup loc="post">+</ce:sup> and GFP- Day 8 AFE Cells, Related to Figure 6</ce:label><ce:link locator="mmc3"/></ce:e-component></ce:display></ce:para></ce:section></ce:appendices></body><tail view="all"><ce:bibliography id="cebib0010" view="all"><ce:section-title id="sectitle0145">References</ce:section-title><ce:bibliography-sec id="cebibsec0010" view="all"><ce:bib-reference id="bib1"><ce:label>Arnold et al., 2011</ce:label><sb:reference id="sref1"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Arnold</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Sarkar</ce:surname></sb:author><sb:author><ce:given-name>M.A.</ce:given-name><ce:surname>Yram</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Polo</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Bronson</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Sengupta</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Seandel</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Geijsen</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Hochedlinger</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Stem Cell</sb:maintitle></sb:title><sb:volume-nr>9</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>317</sb:first-page><sb:last-page>329</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib2"><ce:label>Asuri et al., 2012</ce:label><sb:reference id="sref2"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Asuri</ce:surname></sb:author><sb:author><ce:given-name>M.A.</ce:given-name><ce:surname>Bartel</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Vazin</ce:surname></sb:author><sb:author><ce:given-name>J.H.</ce:given-name><ce:surname>Jang</ce:surname></sb:author><sb:author><ce:given-name>T.B.</ce:given-name><ce:surname>Wong</ce:surname></sb:author><sb:author><ce:given-name>D.V.</ce:given-name><ce:surname>Schaffer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Ther.</sb:maintitle></sb:title><sb:volume-nr>20</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>329</sb:first-page><sb:last-page>338</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib3"><ce:label>Avilion et al., 2003</ce:label><sb:reference id="sref3"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.A.</ce:given-name><ce:surname>Avilion</ce:surname></sb:author><sb:author><ce:given-name>S.K.</ce:given-name><ce:surname>Nicolis</ce:surname></sb:author><sb:author><ce:given-name>L.H.</ce:given-name><ce:surname>Pevny</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Perez</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Vivian</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Lovell-Badge</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Multipotent cell lineages in early mouse development depend on SOX2 function</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Genes Dev.</sb:maintitle></sb:title><sb:volume-nr>17</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>126</sb:first-page><sb:last-page>140</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib4"><ce:label>Buecker et al., 2010</ce:label><sb:reference id="sref4"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Buecker</ce:surname></sb:author><sb:author><ce:given-name>H.H.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Polo</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Daheron</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Bu</ce:surname></sb:author><sb:author><ce:given-name>T.S.</ce:given-name><ce:surname>Barakat</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Okwieka</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Porter</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Gribnau</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Hochedlinger</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Geijsen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Stem Cell</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>535</sb:first-page><sb:last-page>546</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib5"><ce:label>Chambers et al., 2009</ce:label><sb:reference id="sref5"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.M.</ce:given-name><ce:surname>Chambers</ce:surname></sb:author><sb:author><ce:given-name>C.A.</ce:given-name><ce:surname>Fasano</ce:surname></sb:author><sb:author><ce:given-name>E.P.</ce:given-name><ce:surname>Papapetrou</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Tomishima</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Sadelain</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Studer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>27</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>275</sb:first-page><sb:last-page>280</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib6"><ce:label>Cong et al., 2013</ce:label><sb:reference id="sref6"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Cong</ce:surname></sb:author><sb:author><ce:given-name>F.A.</ce:given-name><ce:surname>Ran</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Cox</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Lin</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Barretto</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Habib</ce:surname></sb:author><sb:author><ce:given-name>P.D.</ce:given-name><ce:surname>Hsu</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Wu</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Jiang</ce:surname></sb:author><sb:author><ce:given-name>L.A.</ce:given-name><ce:surname>Marraffini</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Multiplex genome engineering using CRISPR/Cas systems</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Science</sb:maintitle></sb:title><sb:volume-nr>339</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>819</sb:first-page><sb:last-page>823</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib7"><ce:label>Cradick et al., 2013</ce:label><sb:reference id="sref7"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>T.J.</ce:given-name><ce:surname>Cradick</ce:surname></sb:author><sb:author><ce:given-name>E.J.</ce:given-name><ce:surname>Fine</ce:surname></sb:author><sb:author><ce:given-name>C.J.</ce:given-name><ce:surname>Antico</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Bao</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nucleic Acids Res.</sb:maintitle></sb:title></sb:series><sb:date>2013</sb:date></sb:issue><ce:doi>10.1093/nar/gkt714</ce:doi></sb:host><sb:comment>Published online August 11, 2013</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id="bib8"><ce:label>Dabdoub et al., 2008</ce:label><sb:reference id="sref8"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Dabdoub</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Puligilla</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Jones</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Fritzsch</ce:surname></sb:author><sb:author><ce:given-name>K.S.</ce:given-name><ce:surname>Cheah</ce:surname></sb:author><sb:author><ce:given-name>L.H.</ce:given-name><ce:surname>Pevny</ce:surname></sb:author><sb:author><ce:given-name>M.W.</ce:given-name><ce:surname>Kelley</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sox2 signaling in prosensory domain specification and subsequent hair cell differentiation in the developing cochlea</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle></sb:title><sb:volume-nr>105</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>18396</sb:first-page><sb:last-page>18401</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib9"><ce:label>Davis and Stokoe, 2010</ce:label><sb:reference id="sref9"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Davis</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Stokoe</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Zinc finger nucleases as tools to understand and treat human diseases</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>BMC Med.</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>42</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib10"><ce:label>Dubois et al., 2011</ce:label><sb:reference id="sref10"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>N.C.</ce:given-name><ce:surname>Dubois</ce:surname></sb:author><sb:author><ce:given-name>A.M.</ce:given-name><ce:surname>Craft</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Sharma</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Elliott</ce:surname></sb:author><sb:author><ce:given-name>E.G.</ce:given-name><ce:surname>Stanley</ce:surname></sb:author><sb:author><ce:given-name>A.G.</ce:given-name><ce:surname>Elefanty</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Gramolini</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Keller</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>29</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>1011</sb:first-page><sb:last-page>1018</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib11"><ce:label>Elkabetz et al., 2008</ce:label><sb:reference id="sref11"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Elkabetz</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Panagiotakos</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Al Shamy</ce:surname></sb:author><sb:author><ce:given-name>N.D.</ce:given-name><ce:surname>Socci</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Tabar</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Studer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Genes Dev.</sb:maintitle></sb:title><sb:volume-nr>22</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>152</sb:first-page><sb:last-page>165</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib12"><ce:label>Ellis et al., 2004</ce:label><sb:reference id="sref12"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Ellis</ce:surname></sb:author><sb:author><ce:given-name>B.M.</ce:given-name><ce:surname>Fagan</ce:surname></sb:author><sb:author><ce:given-name>S.T.</ce:given-name><ce:surname>Magness</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Hutton</ce:surname></sb:author><sb:author><ce:given-name>O.</ce:given-name><ce:surname>Taranova</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Hayashi</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>McMahon</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Rao</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Pevny</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Dev. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>26</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>148</sb:first-page><sb:last-page>165</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib13"><ce:label>Evseenko et al., 2010</ce:label><sb:reference id="sref13"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Evseenko</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Zhu</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Schenke-Layland</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Kuo</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Latour</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Ge</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Scholes</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Dravid</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>W.R.</ce:given-name><ce:surname>MacLellan</ce:surname></sb:author><sb:author><ce:given-name>G.M.</ce:given-name><ce:surname>Crooks</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle></sb:title><sb:volume-nr>107</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>13742</sb:first-page><sb:last-page>13747</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib14"><ce:label>Fagman et al., 2011</ce:label><sb:reference id="sref14"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Fagman</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Amendola</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Parrillo</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Zoppoli</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Marotta</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Scarfò</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>De Luca</ce:surname></sb:author><sb:author><ce:given-name>D.P.</ce:given-name><ce:surname>de Carvalho</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Ceccarelli</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>De Felice</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Di Lauro</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Gene expression profiling at early organogenesis reveals both common and diverse mechanisms in foregut patterning</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Dev. Biol.</sb:maintitle></sb:title><sb:volume-nr>359</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>163</sb:first-page><sb:last-page>175</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib15"><ce:label>Fauquier et al., 2008</ce:label><sb:reference id="sref15"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Fauquier</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Rizzoti</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Dattani</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Lovell-Badge</ce:surname></sb:author><sb:author><ce:given-name>I.C.</ce:given-name><ce:surname>Robinson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>SOX2-expressing progenitor cells generate all of the major cell types in the adult mouse pituitary gland</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle></sb:title><sb:volume-nr>105</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>2907</sb:first-page><sb:last-page>2912</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib16"><ce:label>Graham et al., 2003</ce:label><sb:reference id="sref16"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Graham</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Khudyakov</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Ellis</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Pevny</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>SOX2 functions to maintain neural progenitor identity</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Neuron</sb:maintitle></sb:title><sb:volume-nr>39</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>749</sb:first-page><sb:last-page>765</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib17"><ce:label>Green et al., 2011</ce:label><sb:reference id="sref17"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.D.</ce:given-name><ce:surname>Green</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>M.C.</ce:given-name><ce:surname>Nostro</ce:surname></sb:author><sb:author><ce:given-name>S.L.</ce:given-name><ce:surname>d'Souza</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Schaniel</ce:surname></sb:author><sb:author><ce:given-name>I.R.</ce:given-name><ce:surname>Lemischka</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Gouon-Evans</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Keller</ce:surname></sb:author><sb:author><ce:given-name>H.W.</ce:given-name><ce:surname>Snoeck</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>29</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>267</sb:first-page><sb:last-page>272</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib18"><ce:label>Hanna et al., 2010</ce:label><sb:reference id="sref18"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Hanna</ce:surname></sb:author><sb:author><ce:given-name>A.W.</ce:given-name><ce:surname>Cheng</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Saha</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Kim</ce:surname></sb:author><sb:author><ce:given-name>C.J.</ce:given-name><ce:surname>Lengner</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Soldner</ce:surname></sb:author><sb:author><ce:given-name>J.P.</ce:given-name><ce:surname>Cassady</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Muffat</ce:surname></sb:author><sb:author><ce:given-name>B.W.</ce:given-name><ce:surname>Carey</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Jaenisch</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle></sb:title><sb:volume-nr>107</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>9222</sb:first-page><sb:last-page>9227</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib19"><ce:label>Hirata et al., 2002</ce:label><sb:reference id="sref19"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Hirata</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Chamberlain</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Dong</ce:surname></sb:author><sb:author><ce:given-name>D.W.</ce:given-name><ce:surname>Russell</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Targeted transgene insertion into human chromosomes by adeno-associated virus vectors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>20</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>735</sb:first-page><sb:last-page>738</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib20"><ce:label>Hockemeyer et al., 2011</ce:label><sb:reference id="sref20"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Hockemeyer</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Kiani</ce:surname></sb:author><sb:author><ce:given-name>C.S.</ce:given-name><ce:surname>Lai</ce:surname></sb:author><sb:author><ce:given-name>Q.</ce:given-name><ce:surname>Gao</ce:surname></sb:author><sb:author><ce:given-name>J.P.</ce:given-name><ce:surname>Cassady</ce:surname></sb:author><sb:author><ce:given-name>G.J.</ce:given-name><ce:surname>Cost</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Santiago</ce:surname></sb:author><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>Miller</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Genetic engineering of human pluripotent cells using TALE nucleases</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>29</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>731</sb:first-page><sb:last-page>734</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib21"><ce:label>Hou et al., 2013</ce:label><sb:reference id="sref21"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Hou</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>N.E.</ce:given-name><ce:surname>Propson</ce:surname></sb:author><sb:author><ce:given-name>S.E.</ce:given-name><ce:surname>Howden</ce:surname></sb:author><sb:author><ce:given-name>L.F.</ce:given-name><ce:surname>Chu</ce:surname></sb:author><sb:author><ce:given-name>E.J.</ce:given-name><ce:surname>Sontheimer</ce:surname></sb:author><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>Thomson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle></sb:title><sb:volume-nr>110</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>15644</sb:first-page><sb:last-page>15649</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib22"><ce:label>Kelly et al., 2011</ce:label><sb:reference id="sref22"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>O.G.</ce:given-name><ce:surname>Kelly</ce:surname></sb:author><sb:author><ce:given-name>M.Y.</ce:given-name><ce:surname>Chan</ce:surname></sb:author><sb:author><ce:given-name>L.A.</ce:given-name><ce:surname>Martinson</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Kadoya</ce:surname></sb:author><sb:author><ce:given-name>T.M.</ce:given-name><ce:surname>Ostertag</ce:surname></sb:author><sb:author><ce:given-name>K.G.</ce:given-name><ce:surname>Ross</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Richardson</ce:surname></sb:author><sb:author><ce:given-name>M.K.</ce:given-name><ce:surname>Carpenter</ce:surname></sb:author><sb:author><ce:given-name>K.A.</ce:given-name><ce:surname>D'Amour</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Kroon</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>29</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>750</sb:first-page><sb:last-page>756</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib23"><ce:label>Khan et al., 2010</ce:label><sb:reference id="sref23"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>I.F.</ce:given-name><ce:surname>Khan</ce:surname></sb:author><sb:author><ce:given-name>R.K.</ce:given-name><ce:surname>Hirata</ce:surname></sb:author><sb:author><ce:given-name>P.R.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Kho</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Nelson</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Huo</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Zavaljevski</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Ware</ce:surname></sb:author><sb:author><ce:given-name>D.W.</ce:given-name><ce:surname>Russell</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Engineering of human pluripotent stem cells by AAV-mediated gene targeting</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Ther.</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>1192</sb:first-page><sb:last-page>1199</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib24"><ce:label>Khan et al., 2011</ce:label><sb:reference id="sref24"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>I.F.</ce:given-name><ce:surname>Khan</ce:surname></sb:author><sb:author><ce:given-name>R.K.</ce:given-name><ce:surname>Hirata</ce:surname></sb:author><sb:author><ce:given-name>D.W.</ce:given-name><ce:surname>Russell</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>AAV-mediated gene targeting methods for human cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Protoc.</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>482</sb:first-page><sb:last-page>501</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib25"><ce:label>Kiefer, 2007</ce:label><sb:reference id="sref25"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>Kiefer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Back to basics: Sox genes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Dev. Dyn.</sb:maintitle></sb:title><sb:volume-nr>236</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>2356</sb:first-page><sb:last-page>2366</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib26"><ce:label>Kiernan et al., 2005</ce:label><sb:reference id="sref26"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.E.</ce:given-name><ce:surname>Kiernan</ce:surname></sb:author><sb:author><ce:given-name>A.L.</ce:given-name><ce:surname>Pelling</ce:surname></sb:author><sb:author><ce:given-name>K.K.</ce:given-name><ce:surname>Leung</ce:surname></sb:author><sb:author><ce:given-name>A.S.</ce:given-name><ce:surname>Tang</ce:surname></sb:author><sb:author><ce:given-name>D.M.</ce:given-name><ce:surname>Bell</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Tease</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Lovell-Badge</ce:surname></sb:author><sb:author><ce:given-name>K.P.</ce:given-name><ce:surname>Steel</ce:surname></sb:author><sb:author><ce:given-name>K.S.</ce:given-name><ce:surname>Cheah</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sox2 is required for sensory organ development in the mammalian inner ear</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>434</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>1031</sb:first-page><sb:last-page>1035</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib27"><ce:label>Lefebvre et al., 2007</ce:label><sb:reference id="sref27"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Lefebvre</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Dumitriu</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Penzo-Méndez</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Han</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Pallavi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Int. J. Biochem. Cell Biol.</sb:maintitle></sb:title><sb:volume-nr>39</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>2195</sb:first-page><sb:last-page>2214</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib28"><ce:label>Li et al., 2011</ce:label><sb:reference id="sref28"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Sun</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Wei</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Ambasudhan</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Xia</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Talantova</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Lin</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Kim</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle></sb:title><sb:volume-nr>108</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>8299</sb:first-page><sb:last-page>8304</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib29"><ce:label>Longmire et al., 2012</ce:label><sb:reference id="sref29"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>T.A.</ce:given-name><ce:surname>Longmire</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Ikonomou</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Hawkins</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Christodoulou</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Cao</ce:surname></sb:author><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>Jean</ce:surname></sb:author><sb:author><ce:given-name>L.W.</ce:given-name><ce:surname>Kwok</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Mou</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Rajagopal</ce:surname></sb:author><sb:author><ce:given-name>S.S.</ce:given-name><ce:surname>Shen</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Stem Cell</sb:maintitle></sb:title><sb:volume-nr>10</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>398</sb:first-page><sb:last-page>411</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib30"><ce:label>Lorthongpanich et al., 2008</ce:label><sb:reference id="sref30"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Lorthongpanich</ce:surname></sb:author><sb:author><ce:given-name>S.H.</ce:given-name><ce:surname>Yang</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Piotrowska-Nitsche</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Parnpai</ce:surname></sb:author><sb:author><ce:given-name>A.W.</ce:given-name><ce:surname>Chan</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Development of single mouse blastomeres into blastocysts, outgrowths and the establishment of embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Reproduction</sb:maintitle></sb:title><sb:volume-nr>135</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>805</sb:first-page><sb:last-page>813</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib31"><ce:label>Mali et al., 2013</ce:label><sb:reference id="sref31"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Mali</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Yang</ce:surname></sb:author><sb:author><ce:given-name>K.M.</ce:given-name><ce:surname>Esvelt</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Aach</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Guell</ce:surname></sb:author><sb:author><ce:given-name>J.E.</ce:given-name><ce:surname>DiCarlo</ce:surname></sb:author><sb:author><ce:given-name>J.E.</ce:given-name><ce:surname>Norville</ce:surname></sb:author><sb:author><ce:given-name>G.M.</ce:given-name><ce:surname>Church</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>RNA-guided human genome engineering via Cas9</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Science</sb:maintitle></sb:title><sb:volume-nr>339</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>823</sb:first-page><sb:last-page>826</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib32"><ce:label>Mansour et al., 1988</ce:label><sb:reference id="sref32"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.L.</ce:given-name><ce:surname>Mansour</ce:surname></sb:author><sb:author><ce:given-name>K.R.</ce:given-name><ce:surname>Thomas</ce:surname></sb:author><sb:author><ce:given-name>M.R.</ce:given-name><ce:surname>Capecchi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>336</sb:volume-nr></sb:series><sb:date>1988</sb:date></sb:issue><sb:pages><sb:first-page>348</sb:first-page><sb:last-page>352</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib33"><ce:label>McKnight et al., 2010</ce:label><sb:reference id="sref33"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.D.</ce:given-name><ce:surname>McKnight</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>S.K.</ce:given-name><ce:surname>Kim</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Deconstructing pancreas development to reconstruct human islets from pluripotent stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Stem Cell</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>300</sb:first-page><sb:last-page>308</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib34"><ce:label>Mou et al., 2012</ce:label><sb:reference id="sref34"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Mou</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Zhao</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Sherwood</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Ahfeldt</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Lapey</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Wain</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Sicilian</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Izvolsky</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Musunuru</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Cowan</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Rajagopal</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Stem Cell</sb:maintitle></sb:title><sb:volume-nr>10</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>385</sb:first-page><sb:last-page>397</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib35"><ce:label>Nichols and Smith, 2009</ce:label><sb:reference id="sref35"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Nichols</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Smith</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Naive and primed pluripotent states</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Stem Cell</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>487</sb:first-page><sb:last-page>492</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib36"><ce:label>Nichols et al., 1998</ce:label><sb:reference id="sref36"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Nichols</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Zevnik</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Anastassiadis</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Niwa</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Klewe-Nebenius</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Chambers</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Schöler</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Smith</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell</sb:maintitle></sb:title><sb:volume-nr>95</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>379</sb:first-page><sb:last-page>391</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib37"><ce:label>Okubo et al., 2006</ce:label><sb:reference id="sref37"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Okubo</ce:surname></sb:author><sb:author><ce:given-name>L.H.</ce:given-name><ce:surname>Pevny</ce:surname></sb:author><sb:author><ce:given-name>B.L.</ce:given-name><ce:surname>Hogan</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sox2 is required for development of taste bud sensory cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Genes Dev.</sb:maintitle></sb:title><sb:volume-nr>20</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>2654</sb:first-page><sb:last-page>2659</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib38"><ce:label>Que et al., 2007</ce:label><sb:reference id="sref38"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Que</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Okubo</ce:surname></sb:author><sb:author><ce:given-name>J.R.</ce:given-name><ce:surname>Goldenring</ce:surname></sb:author><sb:author><ce:given-name>K.T.</ce:given-name><ce:surname>Nam</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Kurotani</ce:surname></sb:author><sb:author><ce:given-name>E.E.</ce:given-name><ce:surname>Morrisey</ce:surname></sb:author><sb:author><ce:given-name>O.</ce:given-name><ce:surname>Taranova</ce:surname></sb:author><sb:author><ce:given-name>L.H.</ce:given-name><ce:surname>Pevny</ce:surname></sb:author><sb:author><ce:given-name>B.L.</ce:given-name><ce:surname>Hogan</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Development</sb:maintitle></sb:title><sb:volume-nr>134</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>2521</sb:first-page><sb:last-page>2531</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib39"><ce:label>Que et al., 2009</ce:label><sb:reference id="sref39"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Que</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Luo</ce:surname></sb:author><sb:author><ce:given-name>R.J.</ce:given-name><ce:surname>Schwartz</ce:surname></sb:author><sb:author><ce:given-name>B.L.</ce:given-name><ce:surname>Hogan</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Multiple roles for Sox2 in the developing and adult mouse trachea</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Development</sb:maintitle></sb:title><sb:volume-nr>136</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>1899</sb:first-page><sb:last-page>1907</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib40"><ce:label>Radecke et al., 2010</ce:label><sb:reference id="sref40"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Radecke</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Radecke</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Cathomen</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Schwarz</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Zinc-finger nuclease-induced gene repair with oligodeoxynucleotides: wanted and unwanted target locus modifications</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Ther.</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>743</sb:first-page><sb:last-page>753</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib41"><ce:label>Rizzino, 2009</ce:label><sb:reference id="sref41"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Rizzino</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sox2 and Oct-3/4: a versatile pair of master regulators that orchestrate the self-renewal and pluripotency of embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Wiley Interdiscip. Rev. Syst. Biol. Med.</sb:maintitle></sb:title><sb:volume-nr>1</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>228</sb:first-page><sb:last-page>236</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib42"><ce:label>Rossant, 2004</ce:label><sb:reference id="sref42"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Rossant</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Lineage development and polar asymmetries in the peri-implantation mouse blastocyst</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Semin. Cell Dev. Biol.</sb:maintitle></sb:title><sb:volume-nr>15</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>573</sb:first-page><sb:last-page>581</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib43"><ce:label>Saliem et al., 2012</ce:label><sb:reference id="sref43"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Saliem</ce:surname></sb:author><sb:author><ce:given-name>B.G.</ce:given-name><ce:surname>Ericzon</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Ellis</ce:surname></sb:author><sb:author><ce:given-name>O.</ce:given-name><ce:surname>Hovatta</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Götherström</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Isolation and characterization of mesenchymal stem cells from human fetal liver; potential candidates for replacement therapy in liver disease</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Liver: Dis. Transplant.</sb:maintitle></sb:title><sb:volume-nr>1</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>2</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib44"><ce:label>Shin et al., 2006</ce:label><sb:reference id="sref44"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Shin</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Mitalipova</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Noggle</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Tibbitts</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Venable</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Rao</ce:surname></sb:author><sb:author><ce:given-name>S.L.</ce:given-name><ce:surname>Stice</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Long-term proliferation of human embryonic stem cell-derived neuroepithelial cells using defined adherent culture conditions</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Stem Cells</sb:maintitle></sb:title><sb:volume-nr>24</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>125</sb:first-page><sb:last-page>138</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib45"><ce:label>Smith-Arica et al., 2003</ce:label><sb:reference id="sref45"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.R.</ce:given-name><ce:surname>Smith-Arica</ce:surname></sb:author><sb:author><ce:given-name>A.J.</ce:given-name><ce:surname>Thomson</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Ansell</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Chiorini</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Davidson</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>McWhir</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Infection efficiency of human and mouse embryonic stem cells using adenoviral and adeno-associated viral vectors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cloning Stem Cells</sb:maintitle></sb:title><sb:volume-nr>5</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>51</sb:first-page><sb:last-page>62</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib46"><ce:label>Song et al., 2010</ce:label><sb:reference id="sref46"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Song</ce:surname></sb:author><sb:author><ce:given-name>S.K.</ce:given-name><ce:surname>Chung</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Xu</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Modeling disease in human ESCs using an efficient BAC-based homologous recombination system</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Stem Cell</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>80</sb:first-page><sb:last-page>89</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib47"><ce:label>Stewart et al., 2006</ce:label><sb:reference id="sref47"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.H.</ce:given-name><ce:surname>Stewart</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Bossé</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Chadwick</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Menendez</ce:surname></sb:author><sb:author><ce:given-name>S.C.</ce:given-name><ce:surname>Bendall</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Bhatia</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Methods</sb:maintitle></sb:title><sb:volume-nr>3</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>807</sb:first-page><sb:last-page>815</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib48"><ce:label>Takahashi et al., 2007</ce:label><sb:reference id="sref48"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Takahashi</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Tanabe</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Ohnuki</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Narita</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Ichisaka</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Tomoda</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Yamanaka</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Induction of pluripotent stem cells from adult human fibroblasts by defined factors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell</sb:maintitle></sb:title><sb:volume-nr>131</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>861</sb:first-page><sb:last-page>872</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib49"><ce:label>Trapnell et al., 2012</ce:label><sb:reference id="sref49"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Trapnell</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Roberts</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Goff</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Pertea</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Kim</ce:surname></sb:author><sb:author><ce:given-name>D.R.</ce:given-name><ce:surname>Kelley</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Pimentel</ce:surname></sb:author><sb:author><ce:given-name>S.L.</ce:given-name><ce:surname>Salzberg</ce:surname></sb:author><sb:author><ce:given-name>J.L.</ce:given-name><ce:surname>Rinn</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Pachter</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Protoc.</sb:maintitle></sb:title><sb:volume-nr>7</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>562</sb:first-page><sb:last-page>578</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib50"><ce:label>Trapnell et al., 2013</ce:label><sb:reference id="sref50"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Trapnell</ce:surname></sb:author><sb:author><ce:given-name>D.G.</ce:given-name><ce:surname>Hendrickson</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Sauvageau</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Goff</ce:surname></sb:author><sb:author><ce:given-name>J.L.</ce:given-name><ce:surname>Rinn</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Pachter</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Differential analysis of gene regulation at transcript resolution with RNA-seq</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>31</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>46</sb:first-page><sb:last-page>53</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib51"><ce:label>Wang et al., 2006</ce:label><sb:reference id="sref51"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Rao</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Chu</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Shen</ce:surname></sb:author><sb:author><ce:given-name>D.N.</ce:given-name><ce:surname>Levasseur</ce:surname></sb:author><sb:author><ce:given-name>T.W.</ce:given-name><ce:surname>Theunissen</ce:surname></sb:author><sb:author><ce:given-name>S.H.</ce:given-name><ce:surname>Orkin</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A protein interaction network for pluripotency of embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>444</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>364</sb:first-page><sb:last-page>368</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib52"><ce:label>Wang et al., 2011</ce:label><sb:reference id="sref52"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>R.T.</ce:given-name><ce:surname>Rodriguez</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Ghodasara</ce:surname></sb:author><sb:author><ce:given-name>S.K.</ce:given-name><ce:surname>Kim</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Targeting SOX17 in human embryonic stem cells creates unique strategies for isolating and analyzing developing endoderm</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Stem Cell</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>335</sb:first-page><sb:last-page>346</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib53"><ce:label>Willert et al., 2003</ce:label><sb:reference id="sref53"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Willert</ce:surname></sb:author><sb:author><ce:given-name>J.D.</ce:given-name><ce:surname>Brown</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Danenberg</ce:surname></sb:author><sb:author><ce:given-name>A.W.</ce:given-name><ce:surname>Duncan</ce:surname></sb:author><sb:author><ce:given-name>I.L.</ce:given-name><ce:surname>Weissman</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Reya</ce:surname></sb:author><sb:author><ce:given-name>J.R.</ce:given-name><ce:surname>Yates</ce:surname><ce:suffix>3rd</ce:suffix></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Nusse</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Wnt proteins are lipid-modified and can act as stem cell growth factors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>423</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>448</sb:first-page><sb:last-page>452</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib54"><ce:label>Yuan et al., 2011</ce:label><sb:reference id="sref54"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.H.</ce:given-name><ce:surname>Yuan</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Martin</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Elia</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Flippin</ce:surname></sb:author><sb:author><ce:given-name>R.I.</ce:given-name><ce:surname>Paramban</ce:surname></sb:author><sb:author><ce:given-name>M.P.</ce:given-name><ce:surname>Hefferan</ce:surname></sb:author><sb:author><ce:given-name>J.G.</ce:given-name><ce:surname>Vidal</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Mu</ce:surname></sb:author><sb:author><ce:given-name>R.L.</ce:given-name><ce:surname>Killian</ce:surname></sb:author><sb:author><ce:given-name>M.A.</ce:given-name><ce:surname>Israel</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>PLoS ONE</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>e17540</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib55"><ce:label>Zou et al., 2009</ce:label><sb:reference id="sref55"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Zou</ce:surname></sb:author><sb:author><ce:given-name>M.L.</ce:given-name><ce:surname>Maeder</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Mali</ce:surname></sb:author><sb:author><ce:given-name>S.M.</ce:given-name><ce:surname>Pruett-Miller</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Thibodeau-Beganny</ce:surname></sb:author><sb:author><ce:given-name>B.K.</ce:given-name><ce:surname>Chou</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Ye</ce:surname></sb:author><sb:author><ce:given-name>I.H.</ce:given-name><ce:surname>Park</ce:surname></sb:author><sb:author><ce:given-name>G.Q.</ce:given-name><ce:surname>Daley</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Stem Cell</sb:maintitle></sb:title><sb:volume-nr>5</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>97</sb:first-page><sb:last-page>110</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article></xocs:serial-item></xocs:doc>
